FedInvent™ Patents
Patent Details for Tuesday, April 20, 2010
This page was updated on Monday, March 27, 2023 at 01:49 AM GMT
Department of Health and Human Services (HHS)
| US 07699838 | Breen et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Case Western Reserve University (Cleveland, Ohio) |
| INVENTOR(S) | Michael S. Breen (Streetsboro, Ohio); David L. Wilson (Mayfield Heights, Ohio); Gerald M. Saidel (Cleveland, Ohio) |
| ABSTRACT | A system and methods for modeling the death of tissue cells that are thermally treated using thermal treatment devices is disclosed. A cell-death model accurately predicts, in real-time, which voxels of cells are dead or are about to die as the thermal treatment is applied to these cells. The effects of thermal treatment are monitored by a thermal measurement device which feeds thermal information to the cell-death model. The cell-death model accounts for the temperature of each voxel of tissue cells with respect to a temperature threshold value and the duration over which the thermal treatment is applied. When the thermal measurement device is an imaging device, the results of the thermal treatment may be displayed to the user in real-time. As a result, a user of the thermal treatment device can determine, in real-time, which target voxels of cells he has killed and which still need to be killed. The user can also more easily avoid inadvertently killing healthy tissue that he does not intend to kill. The cell-death model may be implemented in software on the thermal measurement device, on the thermal treatment device, or on a separate processing device which interfaces to and communicates with at least one of the thermal measurement device and the thermal treatment device. |
| FILED | Wednesday, February 16, 2005 |
| APPL NO | 11/058882 |
| ART UNIT | 3739 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Surgery 66/20 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700073 | Baldwin et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina) |
| INVENTOR(S) | Albert S. Baldwin (Chapel Hill, North Carolina); James C. Cusack (Chapel Hill, North Carolina); Marty W. Mayo (Durham, North Carolina); Cun-Yu Wang (Chapel Hill, North Carolina) |
| ABSTRACT | The use of NF-κB inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described. |
| FILED | Wednesday, September 27, 2006 |
| APPL NO | 11/535738 |
| ART UNIT | 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/1.110 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700085 | Stern et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Trustees of Columbia University in the City of New York (New York, New York) |
| INVENTOR(S) | David M. Stern (Augusta, Georgia); Ann Marie Schmidt (Franklin Lakes, New Jersey) |
| ABSTRACT | The present invention provides a method for treating symptoms of diabetes in a diabetic subject which comprises administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts so as to treat chronic symptoms of diabetes in the subject. |
| FILED | Thursday, May 20, 2004 |
| APPL NO | 10/850861 |
| ART UNIT | 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/78.60 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700095 | Xu et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Yale University (New Haven, Connecticut) |
| INVENTOR(S) | Jianchao Xu (Bethany, Connecticut); Gary Desir (Woodbridge, Connecticut) |
| ABSTRACT | The present invention provides for the identification, isolation and uses of mammalian Monoamine Oxidase C (MAO-C), also known as renalase. |
| FILED | Monday, March 21, 2005 |
| APPL NO | 10/593099 |
| ART UNIT | 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/94.400 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700102 | Hall et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Dana-Farber Cancer Institute (Boston, Massachusetts); Institut National de la Sante et de la Recherche Medicale (INSERM) (Paris Cedex, France) |
| INVENTOR(S) | Kathryn T. Hall (Boston, Massachusetts); Gordon J. Freeman (Brookline, Massachusetts); Joachim L. Schultze (Cologne, Germany); Vassiliki A. Boussiotis (Brookline, Massachusetts); Lee M. Nadler (Newton, Massachusetts); Laurence Boumsell (Creteil, France); Armand Bensussan (Creteil, France) |
| ABSTRACT | Isolated nucleic acid molecules encoding novel CD100 molecules which stimulate a leukocyte response, such as a B cell response, including B cell aggregation, B cell differentiation, B cell survival, and/or T cell proliferation are disclosed. These novel molecules have a certain homology to semaphorins, proteins which are growth cone guidance molecules that are critical for guiding growing axons of neurons to their targets. In addition to isolated nucleic acids molecules, antisense nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced are also described. The invention further provides isolated CD100 proteins, fusion proteins and active fragments thereof. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. |
| FILED | Monday, December 16, 2002 |
| APPL NO | 10/320769 |
| ART UNIT | 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/153.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700107 | Frangione et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | New York University (New York, New York) |
| INVENTOR(S) | Blas Frangione (New York, New York); Thomas Wisniewski (Staten Island, New York); Einar M. Sigurdsson (Scarsdale, New York) |
| ABSTRACT | The present invention relates to synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β which can be used alone or conjugated to an immunostimulatory molecule in an immunizing composition for inducing an immune response to amyloid β peptides and amyloid deposits. |
| FILED | Friday, September 19, 2008 |
| APPL NO | 12/234456 |
| ART UNIT | 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/184.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700111 | Miller et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of Michigan (Ann Arbor, Michigan) |
| INVENTOR(S) | Josef M. Miller (Ann Arbor, Michigan); Richard A. Altschuler (Ann Arbor, Michigan); Yehoash Raphael (Ann Arbor, Michigan) |
| ABSTRACT | The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to treatments to facilitate the protection and re-growth of the auditory nerve. The present invention further provides methods of preventing hair cell loss and the accompanying loss in hearing. The present invention thus provides novel interventions for a variety of hearing impairments. |
| FILED | Thursday, January 16, 2003 |
| APPL NO | 10/345731 |
| ART UNIT | 1649 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/198.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700113 | Liaw |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Maine Medical Research Institute, a division of Maine Medical Center (Scarborough, Maine) |
| INVENTOR(S) | Lucy Liaw (South Portland, Maine) |
| ABSTRACT | The present invention relates to the ability of constitutively active Notch 2 to function as an inhibitor of breast cancer. The invention provides methods and compositions for inhibiting breast cancer cells by using hNotch2ICD polypeptides. |
| FILED | Friday, October 19, 2007 |
| APPL NO | 11/975522 |
| ART UNIT | 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/198.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700118 | Behr et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California) |
| INVENTOR(S) | Marcel Behr (Montreal, Canada); Peter Small (Seattle, Washington); Gary Schoolnik (Stanford, California); Michael A. Wilson (Austin, Texas) |
| ABSTRACT | Specific genetic deletion are identified in mycobacteria isolates, including variations in the M. tuberculosis genome sequence between isolates, and numerous deletion present in BCG as compared to M. tb. These deletions are used as markers to distinguish between pathogenic and avirulent strains, and as a marker for particular M. tb isolates. Deletions specific to vaccine strains of BCG are useful in determining whether a positive tuberculin skin test is indicative of actual tuberculosis infection. The deleted sequences may be re-introduced into BCG to improve the efficacy of vaccination. Alternatively, the genetic sequence that corresponds to the deletion(s) are deleted from M. bovis or M. tubercuosis to attenuate the pathogenic bacteria. |
| FILED | Friday, March 14, 2008 |
| APPL NO | 12/049063 |
| ART UNIT | 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/248.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700122 | Kolesnikov et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Memorial Sloan-Kettering Cancer Center (New York, New York) |
| INVENTOR(S) | Yuri Kolesnikov (Cresskill, New Jersey); Gavril W. Pasternak (New York, New York) |
| ABSTRACT | A topical opioid paradigm was developed to determine analgesic peripheral effects of morphine. Topical morphine as well as peptides such as [D-Ala2,MePhe4,Gly(ol)5]enkephalin (DAMGO) produced a potent, dose-dependent analgesia using the radiant heat tailflick assay. The topical drugs potentiated systemic agents, similar to the previously established synergy between peripheral and central sites of action. Local tolerance was rapidly produced by repeated daily topical exposure to morphine. Topical morphine tolerance was effectively blocked by the N-Methyl-D-Aspartate (NMDA) receptors antagonist MK801 and ketamine given either systemically or topically. NMDA receptor antagonists reversed pre-existing morphine tolerance. The activity of topical NMDA antagonists to block local morphine tolerance suggests that peripheral NMDA receptors mediate topical morphine tolerance. Morphine was cross tolerant to [D-Ala2,MePhe4,Gly(ol)5]enkephalin (DAMGO), but not to morphine-6β-glucuronide, implying different mechanisms of action. These observations have great importance in the design and use of opioids clinically. Topical pharmaceutical compositions comprising an analgesic that functions through an opiate receptor and an NMDA receptor antagonist for producing analgesia without inducing tolerance are described. |
| FILED | Thursday, July 15, 1999 |
| APPL NO | 09/806645 |
| ART UNIT | 1627 — Organic Chemistry |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/400 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700134 | Laurell et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of Michigan (Ann Arbor, Michigan) |
| INVENTOR(S) | Goran Laurell (Stockholm, Sweden); Andreas Ekborn (Stockholm, Sweden); Josef Miller (Ann Arbor, Michigan); Hans Ehrsson (Stockholm, Sweden) |
| ABSTRACT | The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to methods and compositions for the prevention of chemical (e.g., cisplatin) induced deafness. The present invention thus provides methods of improving the outcome of subjects treated with cisplatin. |
| FILED | Thursday, January 16, 2003 |
| APPL NO | 10/345802 |
| ART UNIT | 1627 — Organic Chemistry |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/659 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700273 | Golding et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Department of Health and Human Services (Washington, District of Columbia) |
| INVENTOR(S) | Hana Golding (Rockville, Maryland); Surender Khurana (Bethesda, Maryland) |
| ABSTRACT | The present invention relates, e.g., to an isolated peptide comprising a sequence of contiguous amino acids that is at least about 60% identical (e.g., at least about 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98% or 100% identical) to the sequence E-W-Q-K-E-G-L-V-T-L-W-L (SEQ ID NO:1), or an active variant of an isolated peptide comprising SEQ ID NO:1. Neutralizing antibodies generated by, or specific for, such peptides are also described, in particular antibodies which are specific for the HIV co-receptor, CCR5, and which inhibit infection of a host cell by HIV. Neutralizing single strand and complete human monoclonal antibodies against CCR5 are described. Methods of using such peptides or antibodies, for inhibiting infection by HIV, are also described. |
| FILED | Monday, April 11, 2005 |
| APPL NO | 11/578122 |
| ART UNIT | 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/5 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700284 | Romanov et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Attagene, Inc. (Morrisville, North Carolina) |
| INVENTOR(S) | Sergei R. Romanov (Chapel Hill, North Carolina); Alex Medvedev (Durham, North Carolina); Sergei S. Makarov (Chapel Hill, North Carolina) |
| ABSTRACT | Compositions, methods and kits are provided that are useful, for example, for determining activities of multiple cis-regulatory sequences, such as promoters and enhancers, and/or multiple trans-acting factors, such as transcription factors, in a cell. In particular, in certain embodiments, compositions are provided comprising a population of polynucleotide reporter transcription units (RTUs) in which each RTU comprises a reporter sequence, a processing tag located in the reporter sequence; and a cis-regulatory element operably linked to the reporter sequence, wherein the reporter sequences between any two RTUs in the population, outside of the processing tags, are substantially identical and wherein the positions of the processing tags within the reporter sequences distinguish between any two RTUs differing, for example, in their cis-regulatory elements. The compositions, methods and kits can further be used, for example, to identify a cell type or disease state, for example, in a biological organism. |
| FILED | Thursday, November 10, 2005 |
| APPL NO | 11/271190 |
| ART UNIT | 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/6 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700288 | Dahlberg et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Wisconsin Alumni Research Foundation (Madison, Wisconsin) |
| INVENTOR(S) | James E. Dahlberg (Madison, Wisconsin); Peggy S. Eis (Fitchburg, Wisconsin); Wayne Tam (Forest Hills, New York); Elsebet Lund (Madison, Wisconsin) |
| ABSTRACT | The invention provides methods for diagnosing B-cell lymphoma in an animal. In particular, the invention provides methods for distinguishing an animal having diffuse large B-cell lymphoma (DLBCL) with an activated B-cell (ABC) phenotype from an animal having DLBCL with a non-activated germinal-center (GC) phenotype. The invention also provides methods for identifying compounds for treating B-cell lymphoma. The invention further provides reagents and methods for determining the amount of miR-155 in sample isolated from an animal. In this regard, the invention provides a set of oligonucleotides for determining the amount of miR-155 in sample isolated from an animal. |
| FILED | Monday, February 13, 2006 |
| APPL NO | 11/352837 |
| ART UNIT | 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/6 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700292 | Morton et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Bringham and Woman's Hospital, Inc. (Boston, Massachusetts) |
| INVENTOR(S) | Cynthia Morton (Newton, Massachusetts); Jennelle Hodge (Brookline, Massachusetts); Karen Gross Huyck (Cambridge, Massachusetts) |
| ABSTRACT | The present invention is directed to diagnostic assays that can be used to determine if a woman carries an allelic form of the HMGA2 gene that predisposes her to the formation of fibroid tumors. The invention also encompasses vectors containing this allele, cells transformed with these vectors and transgenic animals that carry at least one copy of the allele. |
| FILED | Tuesday, November 14, 2006 |
| APPL NO | 11/598623 |
| ART UNIT | 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/6 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700293 | Chinnaiyan |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of Michigan (Ann Arbor, Michigan) |
| INVENTOR(S) | Arul M. Chinnaiyan (Plymouth, Michigan) |
| ABSTRACT | The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides gene expression profiles associated with prostate cancers. Genes identified as cancer markers using the methods of the present invention find use in the diagnosis and characterization of prostate cancer. In addition, the genes provide targets for cancer drug screens and therapeutic applications. |
| FILED | Thursday, October 25, 2007 |
| APPL NO | 11/924415 |
| ART UNIT | 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/6 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700301 | Wood et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Dana-Farber Cancer Institute Inc. (Boston, Massachusetts); Wyeth (Madison, New Jersey) |
| INVENTOR(S) | Clive R. Wood (Boston, Massachusetts); Gordon J. Freeman (Brookline, Massachusetts); Divya Chaudhary (Andover, Massachusetts) |
| ABSTRACT | Disclosed are screening assays for identifying compounds which modulate the activity of, or signaling via, B7-4, or PD-1, especially which modulate the binding of B7-4 or PD-1 to a target molecule. |
| FILED | Monday, September 11, 2006 |
| APPL NO | 11/519186 |
| ART UNIT | 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/7.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700308 | Dale-Crunk et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of Washington (Seattle, Washington) |
| INVENTOR(S) | Beverly A. Dale-Crunk (Ellensburg, Washington); Janet R. Kimball (Seattle, Washington); Renchuan Tao (Guangxi, China PRC) |
| ABSTRACT | The present invention provides methods for determining whether a human being is susceptible to dental caries. The methods each include the steps of measuring the amount of α-defensins HNP 1, HNP 2 and HNP 3 in saliva obtained from a human being, and determining whether a reduced amount of the α-defensins HNP 1, HNP 2 and HNP 3 is present in the saliva, thereby determining whether the human being is susceptible to dental caries. |
| FILED | Monday, August 29, 2005 |
| APPL NO | 11/214474 |
| ART UNIT | 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/7.320 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700323 | Willis et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Board of Trustees of the Leland Stanford Junior University (Stanford, California) |
| INVENTOR(S) | Thomas D Willis (San Francisco, California); Paul Hardenbol (Los Altos, California); Maneesh Jain (Menlo Park, California); Viktor Stolc (Cupertino, California); Mostafa Ronaghi (Palo Alto, California); Ronald W Davis (Palo Alto, California) |
| ABSTRACT | The invention is directed to novel methods of multiplexing nucleic acid reactions, including amplification, detection and genotyping. The invention relies on the use of precircle probes that are circularized in the presence of the corresponding target nucleic acids, cleaved, and then amplified. |
| FILED | Thursday, April 15, 2004 |
| APPL NO | 10/826633 |
| ART UNIT | 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/91.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700324 | Issa et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Johns Hopkins University School of Medicine (Baltimore, Maryland) |
| INVENTOR(S) | Jean-Pierre Issa (Timonium, Maryland); Stephen Baylin (Baltimore, Maryland); Minoru Toyota (Baltimore, Maryland) |
| ABSTRACT | The present invention provides a method for identifying a methylated CpG containing nucleic acid by contacting a nucleic acid with a methylation sensitive restriction endonuclease that cleaves unmethylated CpG sites and contacting the sample with an isoschizomer of the methylation sensitive restriction endonuclease, which cleaves both methylated and unmethylated CpG sites. The method also includes amplification of the CpG-containing nucleic acid using CpG-specific oligonucleotide primers A method is also provided for detecting an age associated disorder by identification of a methylated CpG containing nucleic acid. A method is further provided for evaluation the response of a cell to an agent A kit useful for detection of a CpG containing nucleic acid is also provided. Nucleic acid sequences encoding novel methylated clones. |
| FILED | Monday, May 10, 1999 |
| APPL NO | 09/309175 |
| ART UNIT | 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/91.200 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700344 | Paterson et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania) |
| INVENTOR(S) | Yvonne Paterson (Philadelphia, Pennsylvania); Christian Peters (Radnor, Pennsylvania); George Gunn (Collegeville, Pennsylvania) |
| ABSTRACT | The present invention includes compositions, methods and kits for enhancing the immunogenicity of an antigen via fusion to a Listerial protein. The present invention further encompasses Listeria vaccine strains for enhancing the immunogenicity of an antigen. |
| FILED | Thursday, March 16, 2006 |
| APPL NO | 11/376564 |
| ART UNIT | 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/252.300 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700347 | Levin |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Forsyth Institute (Boston, Massachusetts) |
| INVENTOR(S) | Michael Levin (Swampscott, Massachusetts) |
| ABSTRACT | The invention provides apparatuses, systems, and methods for conducting assays in aquatic animals. The apparatuses, systems, and methods of the invention can be used to identify and/or characterize compounds that modulate morphological, anatomical, or behavioral characteristics. The apparatuses, systems, and methods of the invention can be used to identify and/or characterize compounds that modulate learning or memory. |
| FILED | Thursday, June 29, 2006 |
| APPL NO | 11/477259 |
| ART UNIT | 1641 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/288.400 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700354 | Rich |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | HemoGenix, Inc. (Colorado Springs, Colorado) |
| INVENTOR(S) | Ivan N. Rich (Colorado Springs, Colorado) |
| ABSTRACT | The present invention relates generally to high-throughput assay methods that determine the proliferative status of hematopoietic stem and progenitor cells. The present invention further relates to high-throughput assays for screening compounds that modulate the growth of hematopoietic stem and progenitor cells and for identifying subpopulations thereof that are suitable for transplantation. The assay of the present invention is particularly useful for quality control and monitoring of the growth potential in the stem cell transplant setting and would provide improved control over the reconstitution phase of transplanted cells. |
| FILED | Monday, March 17, 2008 |
| APPL NO | 12/049815 |
| ART UNIT | 1641 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/375 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700543 | Baldwin et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina) |
| INVENTOR(S) | Albert S. Baldwin (Chapel Hill, North Carolina); James C. Cusack (Chapel Hill, North Carolina); Marty W. Mayo (Durham, North Carolina); Cun-Yu Wang (Chapel Hill, North Carolina) |
| ABSTRACT | The use of NF-κB inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described. When chemotherapeutic compounds and radiation activate NF-κB within cells, the cells are more resistant to the cytotoxic effects of these treatments. Inhibition of NF-κB activation is disclosed to provide a method to improve the efficacy of these cancer therapies. |
| FILED | Tuesday, November 02, 2004 |
| APPL NO | 10/979403 |
| ART UNIT | 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/2 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700545 | Baldwin et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina) |
| INVENTOR(S) | Albert S. Baldwin (Chapel Hill, North Carolina); James C. Cusack (Chapel Hill, North Carolina); Marty W. Mayo (Durham, North Carolina); Cun-Yu Wang (Chapel Hill, North Carolina) |
| ABSTRACT | The use of NF-κB inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described. |
| FILED | Wednesday, September 27, 2006 |
| APPL NO | 11/535720 |
| ART UNIT | 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/2 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700547 | Nadel et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of California (Oakland, California) |
| INVENTOR(S) | Jay A. Nadel (San Francisco, California); Kiyoshi Takeyama (San Francisco, California) |
| ABSTRACT | Hypersecretion of mucus in the lungs is inhibited by the administration of an epidermal growth factor receptor (EGF-R) antagonist. The EGF-R antagonist may be in the form of a small organic molecule, an antibody, or portion of an antibody that binds to and blocks the EGF receptor. The EGF-R antagonist is preferably administered by injection in an amount sufficient to inhibit formation of goblet cells in pulmonary airways. The degranulation of goblet cells that results in airway mucus production is thereby inhibited. Assays for screening candidate agents that inhibit goblet cell proliferation are also provided. |
| FILED | Friday, January 11, 2008 |
| APPL NO | 12/013013 |
| ART UNIT | 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/2 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700555 | Gunton et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Joslin Diabetes Center, Inc. (Boston, Massachusetts) |
| INVENTOR(S) | Jenny Gunton (Sydney, Australia); C. Ronald Kahn (West Newton, Massachusetts) |
| ABSTRACT | The invention provides methods of screening for compounds that increase levels or activity of Aryl hydrocarbon Nuclear Receptor Translocator (ARNT) and/or Hypoxia Inducible Factor 1α (HIF1α), for the treatment and prevention of diabetes-related disorders, including type 1 and type 2 diabetes mellitus, impaired glucose tolerance, insulin resistance and beta cell dysfunction; compounds identified by said screening methods; and methods of using said compounds. Also included are methods for treating or preventing diabetes-related diseases using ARNT and/or HIF1α polypeptides and polynucleotides, and for using information regarding the expression, level or activity of ARNT and/or HIF1α in predictive medicine, e.g., diagnostic assays, prognostic assays, monitoring clinical trials, and pharmacogenetics. |
| FILED | Tuesday, January 16, 2007 |
| APPL NO | 11/653594 |
| ART UNIT | 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/12 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700557 | Backer et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | SibTech, Inc. (Brookfield, Connecticut) |
| INVENTOR(S) | Marina V. Backer (Simsbury, Connecticut); Joseph M. Backer (Simsbury, Connecticut) |
| ABSTRACT | The present invention is directed to an isolated polypeptide including: (1) the A subunit of Shiga-like bacterial toxin, wherein said subunit has the nucleic acid sequence of SEQ ID NO:9; and (2) human vascular endothelial growth factor wherein the growth factor has the nucleic acid sequence of SEQ ID NO:10; wherein the isolated polypeptide possesses ribosome inactivating activity. The present invention is also directed to compositions for inhibiting endothelial cell growth in a patient. |
| FILED | Tuesday, August 14, 2007 |
| APPL NO | 11/891863 |
| ART UNIT | 1649 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/12 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700560 | Creighton et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of Maryland, Baltimore County (Baltimore, Maryland) |
| INVENTOR(S) | Donald J. Creighton (Baltimore, Maryland); Zhe-Bin Zheng (Shanghai, China PRC) |
| ABSTRACT | Compounds comprising two human GlxI inhibitors covalently linked via a chemical linker are provided, wherein each of said two human GlxI inhibitors, which may be the same or different, is an S-substituted glutathione or an S-substituted glutathione prodrug, wherein said GlxI inhibitors each have a γ-glutamyl amino group, wherein said chemical linker is covalently bound to each GlxI inhibitor via said γ-glutamyl amino group, and wherein said chemical linker has a length of at least 50 Angstroms. Monovalent irreversible inactivators of human GlxI are also provided. An antineoplastic composition is provided, which comprises a compound described above and a pharmaceutically acceptable carrier. In vitro and in vivo methods of preventing or inhibiting the growth and proliferation of neoplastic cells and/or tumors are also provided. |
| FILED | Friday, May 28, 2004 |
| APPL NO | 10/559410 |
| ART UNIT | 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/17 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700568 | Li et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Sloan-Kettering Institute for Cancer Research (New York, New York) |
| INVENTOR(S) | Gloria C. Li (New York, New York); Paul W. J. J. Burgman (Astoria, New York) |
| ABSTRACT | This invention provides methods for increasing the susceptibility of cells to DNA-damaging agents, and for treating tumors in a subject, comprising introducing antisense that prevent expression of DNA dependent protein kinase catalytic subunit Ku70 or Ku80, wherein the antisense is in an amount sufficient to increase the sensitivity of the cells and tumors to heat, chemical, or radiation-induced DNA damage. |
| FILED | Thursday, December 28, 2000 |
| APPL NO | 09/750410 |
| ART UNIT | 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/44 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700575 | Andrew et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | |
| INVENTOR(S) | Huang Andrew (Minneapolis, Minnesota); Ching Yuan (Minnetonka, Minnesota); Emily Zins (Golden Valley, Minnesota) |
| ABSTRACT | The present invention provides siRNA specific for myocilin and mutant myocilin, and methods of treating ocular conditions and/or diseases. |
| FILED | Thursday, October 12, 2006 |
| APPL NO | 11/546940 |
| ART UNIT | 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/44 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700587 | Ablordeppey et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Florida A and M University (Tallahassee, Florida) |
| INVENTOR(S) | Seth Y. Ablordeppey (Tallahassee, Florida); Donald M. N. Sikazwe (Tallahassee, Florida) |
| ABSTRACT | Haloperidol analogs that conforms to the structural formulae: wherein: R is H, or —(CH2)n—OH, n is an integer from 0 to 2, and A is a heterocyclic bridging group, consisting essentially of carbon and at least one nitrogen atom, which effectively maintains the distance between the moieties connected thereby such that the compound (1) is incapable of metabolizing to BCPP+ like species, (2) has an affinity for the D2 receptor subtype of 15<D2<250 and (3) functions as a dopamine receptor antagonist, or the structural formulae: wherein: R1 is H, or —(CH2)n—OH, n is an integer from 0 to 2, B is an aza- or diaza-bicyclo group, which effectively maintains the distance between the moieties connected thereby such that the compound is incapable of metabolizing to BCPP+ like species; and Z is —CH— or N; and pharmaceutically acceptable salts, esters, derivatives, metal complexes, conjugates and prodrugs thereof. |
| FILED | Tuesday, September 07, 2004 |
| APPL NO | 10/934769 |
| ART UNIT | 1624 — Organic Chemistry |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/218 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700650 | Van Dyke et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Trustees of Boston University (Boston, Massachusetts); Brigham and Women's Hospital, Inc. (Boston, Massachusetts); University of Southern California (Los Angeles, California) |
| INVENTOR(S) | Thomas E. Van Dyke (West Roxbury, Massachusetts); Nicos A. Petasis (Hacienda Heights, California); Charles N. Serhan (Needham, Massachusetts) |
| ABSTRACT | This invention provides new lipoxin analogs, compositions containing these analogs, and methods of using these compounds and compositions for treating and preventing oral inflammation, including gingivitis, periodontitis, and other forms of periodontal disease. The invention also provides for methods of treating and preventing oral inflammation, including gingivitis, periodontitis, and other forms of periodontal disease with compositions containing COX-2 inhibitors. Further, the invention provides methods for preventing systemic diseases beyond theoral cavity that are related to periodontal disease using the compositions containing lipoxin analogs, COX-2 inhibitors, or both. |
| FILED | Tuesday, March 20, 2001 |
| APPL NO | 10/239444 |
| ART UNIT | 1621 — Organic Chemistry |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/549 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700725 | Ludwig |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | |
| INVENTOR(S) | Linda B. Ludwig (East Aurora, New York) |
| ABSTRACT | Disclosed is a novel HIV gene comprising a set of open reading frames encoded with the template as the plus strand of the proviral DNA, and located in the region of HIV-1 long terminal repeat. The genes encode a set of antisense proteins, (HAPs) as well as smaller proteins, related to, and containing structural motif resembling that of chemokine proteins. Depending upon the ribosomal frameshift, a plurality of proteins may be translated from the antisense RNA. The smaller proteins have similarity with chemokine SDF-1 and may play a role as a cofactor with gp120 in the binding to and entry of HIV to a target cell. |
| FILED | Thursday, December 23, 2004 |
| APPL NO | 11/020772 |
| ART UNIT | 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 530/350 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700726 | Ludwig |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | |
| INVENTOR(S) | Linda B. Ludwig (East Aurora, New York) |
| ABSTRACT | Disclosed is a novel HIV gene comprising a set of open reading frames encoded with the template as the plus strand of the proviral DNA, and located in the region of HIV-1 long terminal repeat. The genes encode a set of antisense proteins, (HAPs) as well as smaller proteins, related to, and containing structural motif resembling that of chemokine proteins. Depending upon the ribosomal frameshift, a plurality of proteins may be translated from the antisense RNA. The smaller proteins have similarity with chemokine SDF-1 and may play a role as a cofactor with gp120 in the binding to and entry of HIV to a target cell. |
| FILED | Thursday, March 10, 2005 |
| APPL NO | 11/076728 |
| ART UNIT | 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 530/350 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700731 | Höök et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Texas A and M University System (College Station, Texas) |
| INVENTOR(S) | Magnus Höök (Houston, Texas); Slawomir Lukomski (Morgantown, West Virginia); Yi Xu (Houston, Texas) |
| ABSTRACT | The present invention provides recombinant triple helical proteins or collagen-like proteins comprising a prokaryotic protein or one or more domains of a prokaryotic protein comprising a collagen-like peptide sequence of repeated Gly-Xaa-Yaa triplets and, optionally, one or more domains from a mammalian collagen. Also provided are expression vectors and host cells containing the expression vectors to produce these recombinant proteins and methods of producing the same. Additionally, antibodies are provided that are directed against a recombinant collagen-like protein that, preferably, binds an integrin. Furthermore, a method of screening for potential therapeutic compounds that inhibit the integrin-binding or integrin-interacting activities of recombinant collagen-like proteins. |
| FILED | Monday, June 08, 2009 |
| APPL NO | 12/455840 |
| ART UNIT | 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Chemistry: Natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 530/356 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700738 | Marks et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of California (Oakland, California) |
| INVENTOR(S) | James D. Marks (Kensington, California); Isin Geren (San Francisco, California); Jianlong Lou (San Bruno, California) |
| ABSTRACT | This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism. |
| FILED | Thursday, January 26, 2006 |
| APPL NO | 11/342271 |
| ART UNIT | 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 530/387.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700759 | Prasad et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Albert Einstein College of Medicine of Yeshiva University (Bronx, New York) |
| INVENTOR(S) | Vinayaka R. Prasad (Yonkers, New York); Pheroze Joshi (Bronx, New York) |
| ABSTRACT | Provided are RNA oligonucleotides having an aptamer flanked by two self-cleaving ribozymes. Vectors encoding the oligonucleotides, and cells transfected with these vectors are also provided. Additionally, methods of inhibiting replication of a virus in a cell, methods of treating an organism with an aptamer, methods of determining whether a test aptamer is effective in inhibiting the function of a target of the aptamer in a cell, and methods of expressing an RNA aptamer in a cell are provided. |
| FILED | Tuesday, November 30, 2004 |
| APPL NO | 10/999686 |
| ART UNIT | 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Organic compounds 536/24.500 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700908 | Wang et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of Washington (Seattle, Washington) |
| INVENTOR(S) | Wei-Chih Wang (Sammamish, Washington); Per G. Reinhall (Seattle, Washington) |
| ABSTRACT | An ultra high speed miniature two dimensional electro-optic image acquisition system uses prisms of varying geometries to control the amount of horizontal deflection and a Bragg grating to control the amount of vertical deflection. A collimating lens array and a Gaussian profile Bragg grating help confine the beam diameter of the deflected light beam. A separate prism further bends light into the vertical direction. A spherical lens focuses light onto a photodetector array for display. |
| FILED | Friday, June 08, 2007 |
| APPL NO | 11/760622 |
| ART UNIT | 2878 — Optics |
| CURRENT CPC | Radiant energy 250/234 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702381 | Gaeta et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Cornell Research Foundation, Inc. (Ithaca, New York) |
| INVENTOR(S) | Alexander L. Gaeta (Ithaca, New York); Dimitre G. Ouzounov (Ithaca, New York); Watt W. Webb (Ithaca, New York); Rebecca M. Williams (Ithaca, New York); Warren R. Zipfel (Ithaca, New York) |
| ABSTRACT | The present invention is directed to a method of applying radiation through an optical fiber for detecting disease within a plant or animal or other penetrable tissue, or imaging a particular tissue of a plant or animal. In addition, fluorescence and nonlinear scattering signals can be detected and localized within a subject by such application of radiation through an optical fiber. The radiation is effective to promote simultaneous multiphoton excitation. The optical fibers are used alone to examine internal regions of tissue, in conjunction with an optical biopsy needle to evaluate sub-surface tissue, or with an endoscope to evaluate tissue within body cavities. The present invention also relates to a device for coupling in radiation from an ultrashort mode-locked laser into the beam path of a microscope. |
| FILED | Monday, August 16, 2004 |
| APPL NO | 10/918950 |
| ART UNIT | 3737 — Selective Visual Display Systems |
| CURRENT CPC | Surgery 6/478 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702395 | Towe et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Arizona Board of Regents, a Body Corporate, Acting for and on Behalf of Arizona State University (Tempe, Arizona) |
| INVENTOR(S) | Bruce Towe (Mesa, Arizona); William R. Crisp (Pasadena Valley, Arizona) |
| ABSTRACT | Methods and devices of stimulating nerves are disclosed. In one embodiment adapted for stimulating excitable tissue, the invention includes drive circuitry (12), an acoustic transducer (14) and a pair of electrodes (28). |
| FILED | Tuesday, August 19, 2003 |
| APPL NO | 10/524955 |
| ART UNIT | 3762 — Refrigeration, Vaporization, Ventilation, and Combustion |
| CURRENT CPC | Surgery: Light, thermal, and electrical application 67/48 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702430 | Srivastava et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Board of Regents of the University of Texas System (Austin, Texas) |
| INVENTOR(S) | Satish K. Srivastava (Galveston, Texas); Aurni Bhatnagar (Prospect, Kentucky); Kota V. Ramana (Galveston, Texas) |
| ABSTRACT | Provided herein is a crystallized ternary structure of human aldose reductase (AR) bound to NADPH and γ-glutamyl-S-(1,2-dicarboxyethyl)cysteinylglycine (DCEG). Also provided are specific inhibitors of glutathione-aldehyde binding to aldose reductase which are designed via at least computer modeling of the ternary AR:NADPH:DCEG structure and methods of designing and of screening the inhibitors for inhibition of glutathione-aldehyde binding to aldose reductase. |
| FILED | Friday, November 18, 2005 |
| APPL NO | 11/282801 |
| ART UNIT | 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Data processing: Vehicles, navigation, and relative location 71/11 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Department of Defense (DOD)
| US 07698983 | Pinto et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Army (Washington, District of Columbia) |
| INVENTOR(S) | Robert P. Pinto (Dover, New Jersey); Gregory Schneck (Morganville, New Jersey); Patricia M. Alameda (Budd Lake, New Jersey); Tom Coradeschi (Hackettstown, New Jersey) |
| ABSTRACT | A portable, self-contained fire control system includes one or more of: 1) the means to provide geodetic positioning and navigational data for the host weapon platform in relation to established coordinate reference systems; 2) the means to digitally communicate with an off-platform command and control network; 3) the means to compute host platform ballistics data; 4) the means to indicate the current weapon orientation and additionally to indicate the horizontal and vertical weapon movements required to aim the weapon; 5) the means to inductively set fuzes for firing; 6) the means for digitally receiving and processing pre-computed mission data through to the fuze/projectile; 7) the means for locally computing mission data; and 8) the means for manually entering pre-computed data into the system. |
| FILED | Monday, October 16, 2006 |
| APPL NO | 11/549784 |
| ART UNIT | 3641 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review |
| CURRENT CPC | Ordnance 089/6.500 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07699519 | Potts |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Mark H. Potts (Williamsfield, Illinois) |
| ABSTRACT | The invention relates to a method and apparatus to carry out the method for extracting petroleum distillate products from alcohol. The inventive method capitalizes on the discovered property that petroleum distillates, such as xylene and limonene, can be dissociated from their tight molecular interaction with alcohol by their higher affinity for water. The method also capitalizes on the discovered property that limonene, in the presence of water, forms terpin hydrate, forming particles that can be removed by filtration. Other, non-limonene petroleum distillates, once dissociated from alcohol, can be removed by distillation. |
| FILED | Monday, September 11, 2006 |
| APPL NO | 11/526891 |
| ART UNIT | 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Agitating 366/296 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07699915 | Lin |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Microfluidic Systems, Inc. (Fremont, California) |
| INVENTOR(S) | Chun-Wah (Phil) Lin (Hayward, California) |
| ABSTRACT | A modified liquid impingement unit is configured to automatically maintain a volume of buffer solution within a determined range, the buffer solution used to collect airborne particles from an impinging airflow. The liquid impingement unit includes a first end of an air nozzle and a first end of a vacuum tube sealed within collection vessel. A fluid delivery tube is positioned within the vacuum tube such that a first end of the fluid delivery tube is also positioned within the sealed collection vessel. External to the sealed collection vessel, the fluid delivery tube branches from the vacuum tube through an aperture in the vacuum tube. The vacuum tube is coupled to a vacuum pump and the fluid delivery tube is coupled to a fluid pump. A control module provides control signals to the fluid pump such that the fluid pump delivers a second volume of buffer solution from a buffer solution container to the collection vessel via the fluid delivery tube. |
| FILED | Thursday, August 24, 2006 |
| APPL NO | 11/509879 |
| ART UNIT | 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Gas separation: Apparatus 096/413 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700032 | Lu et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Ryan P. Lu (Carlsbad, California); Ayax D. Ramirez (Chula Vista, California); Ozzie Csanadi (San Diego, California); Stephen D. Russell (San Diego, California) |
| ABSTRACT | A laser ablation process is applied to a semiconductor substrate causing the semiconductor material surface and subsurface to be superheated to the point where material is ablated from the material substrate. Optional subsequent laser pulse(s) liquefy the particles, preferably while suspended in air, and the material surface tension causes the liquefied droplet of semiconductor material to form a sphere. The droplet preferably solidifies in air before reaching the substrate of its origin or another substrate for collection. |
| FILED | Monday, July 14, 2008 |
| APPL NO | 12/172366 |
| ART UNIT | 1791 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Plastic and nonmetallic article shaping or treating: Processes 264/400 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700040 | Thomas et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | NDSU-Research Foundation (Fargo, North Dakota) |
| INVENTOR(S) | Johnson Thomas (Fargo, North Dakota); Philip Boudjouk (Fargo, North Dakota) |
| ABSTRACT | Applicants have produced a chromophore and a polymer that are highly sensitive to the presence of various agents, including organophosphates, pesticides, neurotoxins, metal ions, some explosives, and biological toxins. The detection is accomplished by detecting a change in the fluorescence characteristics of the chromophore or polymer when in the presence of the agent to be detected. The chromophore and polymer may be incorporated into sensors of various types, and they are adaptable for potential field use in areas where detection of these types of agents is desired. |
| FILED | Tuesday, January 24, 2006 |
| APPL NO | 11/338261 |
| ART UNIT | 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Chemical apparatus and process disinfecting, deodorizing, preserving, or sterilizing 422/52 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700073 | Baldwin et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina) |
| INVENTOR(S) | Albert S. Baldwin (Chapel Hill, North Carolina); James C. Cusack (Chapel Hill, North Carolina); Marty W. Mayo (Durham, North Carolina); Cun-Yu Wang (Chapel Hill, North Carolina) |
| ABSTRACT | The use of NF-κB inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described. |
| FILED | Wednesday, September 27, 2006 |
| APPL NO | 11/535738 |
| ART UNIT | 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/1.110 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700152 | Laine et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of Michigan (Ann Arbor, Michigan) |
| INVENTOR(S) | Richard M. Laine (Ann Arbor, Michigan); Julien Marchal (Ann Arbor, Michigan); José Azurdia (Guatemala, Guatemala); Roy Rennesund (Auli, Norway) |
| ABSTRACT | Nano- and micron sized metal oxide and mixed metal oxide particles are injected into a high temperature region wherein the temperature is between about 400° C. and less than 2000° C., and collected as particles or as coatings wherein a particulate nature is substantially maintained. The particles are altered in at least one of phase, morphology, composition, and particle size distribution, and may achieve further changes in these characteristics by coinjection of metal oxide precursor in liquid form. |
| FILED | Friday, February 25, 2005 |
| APPL NO | 11/066822 |
| ART UNIT | 1792 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Coating processes 427/212 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700366 | Swager et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Massachusetts Institute of Technology (Cambridge, Massachusetts) |
| INVENTOR(S) | Timothy M. Swager (Newton, Massachusetts); Youngmi Kim (Cambridge, Massachusetts) |
| ABSTRACT | The present invention relates to fluorescent, semiconductive polymers comprising electron withdrawing groups bonded to the polymer. The invention also relates to a method of detecting analytes comprising contacting the analyte with the fluorescent, semiconductive polymers of the present invention. The invention also relates to light emitting devices, photovoltaic devices, and sensors comprising the fluorescent, semiconductive polymers of the present invention. |
| FILED | Monday, December 06, 2004 |
| APPL NO | 11/005634 |
| ART UNIT | 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Chemistry: Analytical and immunological testing 436/172 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700395 | Huffaker et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | STC.UNM (Albuquerque, New Mexico) |
| INVENTOR(S) | Diana L. Huffaker (Albuquerque, New Mexico); Larry R. Dawson (Albuquerque, New Mexico); Ganesh Balakrishnan (Albuquerque, New Mexico) |
| ABSTRACT | Exemplary embodiments provide a semiconductor fabrication method including a combination of monolithic integration techniques with wafer bonding techniques. The resulting semiconductor devices can be used in a wide variety of opto-electronic and/or electronic applications such as lasers, light emitting diodes (LEDs), phototvoltaics, photodetectors and transistors. In an exemplary embodiment, the semiconductor device can be formed by first forming an active-device structure including an active-device section disposed on a thinned III-V substrate. The active-device section can include OP and/or EP VCSEL devices. A high-quality monolithic integration structure can then be formed with low defect density through an interfacial misfit dislocation. In the high-quality monolithic integration structure, a thinned III-V mating layer can be formed over a silicon substrate. The thinned III-V substrate of the active-device structure can subsequently be wafer-bonded onto the thinned III-V mating layer of the high-quality monolithic integration structure forming an optoelectronic semiconductor device on silicon. |
| FILED | Thursday, January 11, 2007 |
| APPL NO | 11/622306 |
| ART UNIT | 2813 — Semiconductors/Memory |
| CURRENT CPC | Semiconductor device manufacturing: Process 438/46 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700419 | Anwar et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia) |
| INVENTOR(S) | Abul F Anwar (Storrs, Connecticut); Richard T. Webster (Bedford, Massachusetts) |
| ABSTRACT | An insulated gate silicon nanowire transistor amplifier structure is provided and includes a substrate formed of dielectric material. A patterned silicon material may be disposed on the substrate and includes at least first, second and third electrodes uniformly spaced on the substrate by first and second trenches. A first nanowire formed in the first trench operates to electrically couple the first and second electrodes. A second nanowire formed in the second trench operates to electrically couple the second and third electrodes. First drain and first source contacts may be respectively disposed on the first and second electrodes and a first gate contact may be disposed to be capacitively coupled to the first nanowire. Similarly, second drain and second source contacts may be respectively disposed on the second and third electrodes and a second gate contact may be disposed to be capacitively coupled to the second nanowire. |
| FILED | Thursday, August 14, 2008 |
| APPL NO | 12/229051 |
| ART UNIT | 2812 — Semiconductors/Memory |
| CURRENT CPC | Semiconductor device manufacturing: Process 438/151 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700498 | Chou et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Princeton University (Princeton, New Jersey) |
| INVENTOR(S) | Stephen Y. Chou (Princeton, New Jersey); Qiangfei Xia (Princeton, New Jersey) |
| ABSTRACT | In accordance with the invention, the structure (10A, 10B) of a patterned nanoscale or near nanoscale device (“nanostructure”) is repaired and/or enhanced by liquifying the patterned device in the presence of appropriate guiding conditions for a period of time and then permitting the device to solidify. Advantageous guiding conditions include adjacent spaced apart or contacting surfaces (12, 13A, 13B) to control surface structure and preserve verticality and unconstrained boundaries to permit smoothing of edge roughness. In an advantageous embodiment, a flat planar surface (12) is disposed overlying a patterned nanostructure surface (13A, 13B) and the surface (13A, 13B) is liquified by a high intensity light source to repair or enhance the nanoscale features. |
| FILED | Monday, May 29, 2006 |
| APPL NO | 11/915090 |
| ART UNIT | 2813 — Semiconductors/Memory |
| CURRENT CPC | Semiconductor device manufacturing: Process 438/760 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700508 | Zhu et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of Americas as represented by the Secretary of the Army (Washington, District of Columbia) |
| INVENTOR(S) | Dongming Zhu (Westlake, Ohio); Robert A. Miller (Brecksville, Ohio) |
| ABSTRACT | A composition for thermal barrier coatings exhibiting improved thermal conductivity and toughness is provided. The composition is comprised of a base majority oxide, a first dopant oxide, at least one small rare earth oxide, at least one large rare earth oxide and at least one toughening oxide. Compared to traditional thermal barrier coatings, a composition of the present invention provides approximately twice the toughness one-third to one-half the thermal conductivity. |
| FILED | Monday, August 28, 2006 |
| APPL NO | 11/510574 |
| ART UNIT | 1794 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Compositions: Ceramic 51/103 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700543 | Baldwin et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina) |
| INVENTOR(S) | Albert S. Baldwin (Chapel Hill, North Carolina); James C. Cusack (Chapel Hill, North Carolina); Marty W. Mayo (Durham, North Carolina); Cun-Yu Wang (Chapel Hill, North Carolina) |
| ABSTRACT | The use of NF-κB inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described. When chemotherapeutic compounds and radiation activate NF-κB within cells, the cells are more resistant to the cytotoxic effects of these treatments. Inhibition of NF-κB activation is disclosed to provide a method to improve the efficacy of these cancer therapies. |
| FILED | Tuesday, November 02, 2004 |
| APPL NO | 10/979403 |
| ART UNIT | 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/2 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700545 | Baldwin et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina) |
| INVENTOR(S) | Albert S. Baldwin (Chapel Hill, North Carolina); James C. Cusack (Chapel Hill, North Carolina); Marty W. Mayo (Durham, North Carolina); Cun-Yu Wang (Chapel Hill, North Carolina) |
| ABSTRACT | The use of NF-κB inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described. |
| FILED | Wednesday, September 27, 2006 |
| APPL NO | 11/535720 |
| ART UNIT | 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/2 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700578 | Guerry et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Patricia Guerry (Silver Spring, Maryland); Mario Artur Monteiro (Guelph, Canada) |
| ABSTRACT | An immunogenic composition, and method of using the composition to elicit an immune response to Campylobacter jejuni. The composition is an isolated polysaccharide polymer composed of one or more forms of disaccharide polymers. |
| FILED | Friday, July 25, 2008 |
| APPL NO | 12/221150 |
| ART UNIT | 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/55 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700710 | Keller et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Teddy M Keller (Fairfax Station, Virginia); Manoj K. Kolel-Veetil (Alexandria, Virginia); Syed B Qadri (Fairfax Station, Virginia) |
| ABSTRACT | A method and a ceramic made therefrom by: providing a composition of a compound having the formula below and a metallic component, and pyrolyzing the composition. R is an organic group. The value n is a positive integer. Q is an acetylenic repeat unit having an acetylene group, crosslinked acetylene group, (MLx)y-acetylene complex, and/or crosslinked (MLx)y-acetylene complex. M is a metal. L is a ligand. The values x and y are positive integers. The metallic component is the (MLx)y-acetylene complex in the compound or a metallic compound capable of reacting with the acetylenic repeat unit to form the (MLx)y-acetylene complex. The ceramic comprises metallic nanoparticles. |
| FILED | Wednesday, March 19, 2008 |
| APPL NO | 12/051179 |
| ART UNIT | 1796 — Organic Chemistry |
| CURRENT CPC | Synthetic resins or natural rubbers 528/25 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700738 | Marks et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of California (Oakland, California) |
| INVENTOR(S) | James D. Marks (Kensington, California); Isin Geren (San Francisco, California); Jianlong Lou (San Bruno, California) |
| ABSTRACT | This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism. |
| FILED | Thursday, January 26, 2006 |
| APPL NO | 11/342271 |
| ART UNIT | 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 530/387.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700756 | Bender et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Southern Illinois University (Carbondale, Illinois) |
| INVENTOR(S) | Kelly S. Bender (Pickneyville, Illinois); Laurie Achenbach (Carbondale, Illinois) |
| ABSTRACT | The present invention is directed to metabolic primers for the detection of perchlorate-reducing bacteria and methods and compositions for use of the same in environmental bioremediation. |
| FILED | Thursday, July 26, 2007 |
| APPL NO | 11/828994 |
| ART UNIT | 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Organic compounds 536/24.330 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700783 | Smith, III et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania) |
| INVENTOR(S) | Amos B Smith, III (Merion, Pennsylvania); Brian Scott Freeze (Arlington, Massachusetts); Ming Xian (Pullman, Washington) |
| ABSTRACT | Processes for synthesizing a compound of Formula (I) are provided by reacting a compound of Formula (i) with a compound of Formula (xx). |
| FILED | Tuesday, October 12, 2004 |
| APPL NO | 10/575136 |
| ART UNIT | 1625 — Organic Chemistry |
| CURRENT CPC | Organic compounds 548/230 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700911 | van Amerom et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of South Florida (Tampa, Florida) |
| INVENTOR(S) | Friso van Amerom (St. Petersburg, Florida); Ashish Chaudhary (St. Petersburg, Florida); Shekhar Bhansali (Tampa, Florida); Robert T. Short (St. Petersburg, Florida); George Steimle (St. Petersburg, Florida) |
| ABSTRACT | A cylindrical ion trap (CIT) mass spectrometer constructed using a non-conductive substrate (LTCC) as the basis for the ring electrode. Photolithography and electroless plating were used to create well-defined conductive areas on the LTCC ring electrode. The inventive method allows for the precise control of establishing conductive areas on a non-conductive substrate through the steps of punching, lamination, firing, metallization and photolithography on the metallized layer. |
| FILED | Monday, March 06, 2006 |
| APPL NO | 11/368770 |
| ART UNIT | 2818 — Semiconductors/Memory |
| CURRENT CPC | Radiant energy 250/281 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700929 | Ting et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Antonio Ting (Silver Spring, Maryland); Ilya Alexeev (West Chester, Pennsylvania); Phillip Sprangle (Great Falls, Virginia); Richard Hubbard (Burke, Virginia); Glenn Rubel (Baldwin, Maryland); Eldridge Briscoe (San Diego, California); Christopher Moore (Prince Frederick, Maryland) |
| ABSTRACT | A system for detecting atmospheric contamination, the system comprising a laser operable to generate an infrared light beam comprising a longitudinal component and a transverse component, the laser remote from the atmospheric contamination, and a processor operable to process a flouresence resulting from contact between the atmospheric contamination and an ultraviolet light being generated from the longitudinal and transverse components of the infrared light of the laser, wherein the processor determines the identity of the fluorescence by comparing the fluorescence to known fluorescence. |
| FILED | Thursday, March 19, 2009 |
| APPL NO | 12/407429 |
| ART UNIT | 2884 — Optics |
| CURRENT CPC | Radiant energy 250/461.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700973 | Shen et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of California (Oakland, California) |
| INVENTOR(S) | Likun Shen (Goleta, California); Sten Johan Heikman (Goleta, California); Umesh Kumar Mishra (Santa Barbara, California) |
| ABSTRACT | A dispersion-free high electron mobility transistor (HEMT), comprised of a substrate; a semi-insulating buffer layer, comprised of gallium nitride (GaN) or aluminum gallium nitride (AlGaN), deposited on the substrate, an AlGaN barrier layer, with an aluminum (Al) mole fraction larger than that of the semi-insulating buffer layer, deposited on the semi-insulating buffer layer, an n-type doped graded AlGaN layer deposited on the AlGaN barrier layer, wherein an Al mole fraction is decreased from a bottom of the n-type doped graded AlGaN layer to a top of the n-type doped graded AlGaN layer, and a cap layer, comprised of GaN or AlGaN with an Al mole fraction smaller than that of the AlGaN barrier layer, deposited on the n-type doped graded AlGaN layer. |
| FILED | Tuesday, October 12, 2004 |
| APPL NO | 10/962911 |
| ART UNIT | 2815 — Semiconductors/Memory |
| CURRENT CPC | Active solid-state devices 257/194 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701027 | Pepper et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | HRL Laboratories, LLC (Malibu, California) |
| INVENTOR(S) | David M. Pepper (Malibu, California); Gilmore J. Dunning (Newbury Park, California); Marvin B. Klein (Pacific Palisades, California); Gerald David Bacher (Carlsbad, California); Bruno Pouet (Los Angeles, California) |
| ABSTRACT | A method and apparatus for a photoinduced electromotive force sensor. The sensor has an active substrate formed of a semi-insulating photoconductor with sufficient carrier trap density to form an effective charge grating and pairs of electrodes disposed on the active substrate, where the sensor is configured to reduce the photovoltaic effect caused by the incident light in the vicinity of the electrodes. The shape or composition of the electrodes may be selected to reduce the photovoltaic effect or the electrodes may be disposed on the substrate to average out the photovoltaic effect arising from each one of the electrodes. |
| FILED | Friday, March 03, 2006 |
| APPL NO | 11/367073 |
| ART UNIT | 2826 — Semiconductors/Memory |
| CURRENT CPC | Active solid-state devices 257/448 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701075 | Holliday |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Sunpower, Inc. (Athens, Ohio) |
| INVENTOR(S) | Ezekiel S. Holliday (Belpre, Ohio) |
| ABSTRACT | An electrical power source including a free-piston Stirling engine driving an alternator to supply power through a bus to a user load and controlled by an engine/alternator controller. A bidirectional DC/DC converter is connected between a battery and the bus. The stroke of the engine piston is modulated between a maximum and a minimum stroke to maintain the bus voltage at a design nominal bus voltage (V1), and charge the battery if it is not charged, when and so long as the bus voltage does not fall below a design nominal bus voltage (V1). The Stirling engine is operated at its maximum piston stroke, and the battery is charged if it is not charged, when the bus voltage is in the range between the design nominal bus voltage (V1) and a design minimum battery charging bus voltage (V2). The Stirling engine is operated at its maximum piston stroke and the battery is disconnected from the bus so it can not charge when the bus voltage is in the range between the design minimum battery charging bus voltage (V2) and a design minimum bus voltage (V3). The Stirling engine is operated at its maximum piston stroke and power is applied from the battery to the bus for maintaining the bus voltage at the design minimum bus voltage (V3) when the power supplied from the alternator operating at its maximum stroke is less than the power demand of the load. |
| FILED | Friday, December 05, 2008 |
| APPL NO | 12/328981 |
| ART UNIT | 2839 — Semiconductors/Memory |
| CURRENT CPC | Prime-mover dynamo plants 290/40.C00 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701078 | Johnson et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia) |
| INVENTOR(S) | Scott V. Johnson (Scottsdale, Arizona); John J. Martin (Gilbert, Arizona) |
| ABSTRACT | A retrofit energization arrangement especially suitable for an aircraft wherein original factory-placed wiring can be reused in common bus form for plural new loads in order to avoid the expense and hazard of disassembling original wiring bundles for new conductor incorporation. Serviceable wiring possibly earlier retired in place or becoming unneeded from equipment removal can, by way of the invention, be used for plural diverse new loads including loads of disparate operating cycle and current requirements for example, even though energized via a common bus. In the disclosed apparatus both energizing current and load control signals are transmitted via the same electrical bus between control location and load areas of the aircraft where control decoding and energy tap-off occur, the latter by switch mode power supply if needed. Control signals of sinusoidal waveform, minimal electromagnetic and radio frequency interference character and limited existing bus filtering attenuation are disclosed; these may be embodied as the Frequency Shift Keying (FSK) or Continuous Tone Coded Squelch System, CTCSS, frequencies used in the radio communication art. Loads of differing types are disclosed as examples in the described embodiment of the invention; additional loads are feasible. Use of the invention in land vehicles, watercraft and building structures is also contemplated. |
| FILED | Monday, August 06, 2007 |
| APPL NO | 11/894638 |
| ART UNIT | 2836 — Electrical Circuits and Systems |
| CURRENT CPC | Electrical transmission or interconnection systems 37/9.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701112 | Choi et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Board of Regents, The University of Texas System (Austin, Texas) |
| INVENTOR(S) | Byung-Jin Choi (Austin, Texas); Sidigata V. Sreenivasan (Austin, Texas); Stephen C. Johnson (Austin, Texas) |
| ABSTRACT | An apparatus to control displacement of a body spaced-apart from a surface includes a flexure system having a first flexure member defining a first axis of rotation and a second flexure member defining a second axis of rotation. A body is coupled to the flexure system to move about a plurality of axes. An actuation system is coupled to the flexure system to selectively constrain movement of the body along a subset of the plurality of axes. |
| FILED | Thursday, April 09, 2009 |
| APPL NO | 12/421170 |
| ART UNIT | 2837 — Electrical Circuits and Systems |
| CURRENT CPC | Electrical generator or motor structure 310/311 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701196 | Hull et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Army (Washington, District of Columbia) |
| INVENTOR(S) | David M. Hull (Adelphi, Maryland); Peter M. Cremona-Simmons (Stafford, Virginia) |
| ABSTRACT | Methods for detecting and classifying loads on alternating current (AC) lines are provided. One such method includes the steps of placing an AC field sensor in AC electric and magnetic fields generated by an AC line, generating an electric field signal representative of the AC electric field received by the AC field sensor, generating a magnetic field signal representative of the AC magnetic field received by the AC field sensor, generating a relative phase signal representative of relative phase changes between the electric and magnetic fields, and processing the relative phase signal to detect and classify loads on the AC line. In another method, relative load vector signals representative of relative magnitude and phase changes in the magnetic field are generated and processed to detect and classify loads on the AC line. |
| FILED | Monday, August 20, 2007 |
| APPL NO | 11/892151 |
| ART UNIT | 2831 — Electrical Circuits and Systems |
| CURRENT CPC | Electricity: Measuring and testing 324/76.770 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701380 | Altes |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Chirp Corporation (La Jolla, California) |
| INVENTOR(S) | Richard Alan Altes (La Jolla, California) |
| ABSTRACT | Phase modulated beam patterns are substituted for the constant-phase versions that have been used in prior synthetic aperture systems. Relative movement between a radar/sonar/ultrasound platform and a point target causes a sequence of echoes from the point target to be phase and amplitude modulated by the beam pattern, as well as by the usual quadratic phase variation caused by range changes. Azimuth, range rate, and azimuth rate estimation, as well as detection in clutter, are substantially improved by appropriate beam pattern phase modulation, which is applied to the transmitter and/or receiver beam patterns. Phase modulated beam patterns are synthesized with array element weighting functions that are designed for high ambiguity function peak-to-sidelobe level, reduction of unwanted ambiguity ridge lines, and adequate spatial sampling. Two dimensional beam pattern phase modulation is useful when the relative motion between a transmit-receive array and multiple targets has both azimuth and elevation components. |
| FILED | Wednesday, March 07, 2007 |
| APPL NO | 11/714797 |
| ART UNIT | 3662 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems |
| CURRENT CPC | Communications: Directive radio wave systems and devices 342/25.F00 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701391 | Curry et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Aerospace Corporation (El Segundo, California) |
| INVENTOR(S) | Samuel J. Curry (Redondo Beach, California); David M. Schwartz (Northridge, California) |
| ABSTRACT | A method for acquiring Global Positioning System (GPS) code includes describing GPS code as a Low Density Parity Check (LDPC) code, and decoding the LDPC code to achieve acquisition by directly solving for the correct code phase. |
| FILED | Wednesday, March 14, 2007 |
| APPL NO | 11/686099 |
| ART UNIT | 3662 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems |
| CURRENT CPC | Communications: Directive radio wave systems and devices 342/357.150 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701404 | McKivergan |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | BAE Systems Information and Electronic Systems Integration Inc. (Nashua, New Hampshire) |
| INVENTOR(S) | Patrick D. McKivergan (Londonderry, New Hampshire) |
| ABSTRACT | A method of operating a higher conductivity broadband loaded meander line antenna (10) is provided wherein the meander line is positioned on a sheet of a lower conductivity material (22) having a conductivity of from about 0.01 siemens/m to about 0.10 siemens/m; and allowing a first electrical current to flow in a first current path in the meander line. An electrical field is formed in the vicinity of the lower conductivity material and a second current flows in a second current path in the lower conductivity material, whereby anti-resonance in the meander line loaded antenna is diminished so that a broadband response can be achieved over bandwidths of 5:1 or more. An assembly for carrying out this method is also disclosed. |
| FILED | Friday, December 19, 2003 |
| APPL NO | 10/557027 |
| ART UNIT | 2821 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems |
| CURRENT CPC | Communications: Radio wave antennas 343/742 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701406 | Horner et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Rob Horner (San Diego, California); Rod Cozad (San Diego, California); Hale Simonds (San Diego, California); Robbi Mangra (San Diego, California) |
| ABSTRACT | A Variable Height/Thickness Ratio Tapered Slot Antenna For Matching Impedance and Power Handling (NC#98542). The apparatus includes a tapered slot antenna having a gap height and a thickness. The tapered slot antenna includes a first antenna element comprising conductive material, configured to receive and transmit RF signals and a second antenna element comprising conductive material, operatively coupled to said first antenna element, configured to receive and transmit RF signals. A correlation between said gap height and said thickness can be represented by an equation. |
| FILED | Wednesday, March 14, 2007 |
| APPL NO | 11/726195 |
| ART UNIT | 2821 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems |
| CURRENT CPC | Communications: Radio wave antennas 343/767 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701638 | Videen |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Army (Washington, District of Columbia) |
| INVENTOR(S) | Gorden Videen (Silver Spring, Maryland) |
| ABSTRACT | A rotatable optical beamsplitter comprises an optically-transparent material and a partially-reflective layer. The optically-transparent material has a unitary spherical exterior surface. The partially-reflective layer is located at least partially within the optically transparent material. The spherically shaped optical beamsplitter demonstrates reduced optical distortion. |
| FILED | Wednesday, January 30, 2008 |
| APPL NO | 12/022313 |
| ART UNIT | 2873 — Optics |
| CURRENT CPC | Optical: Systems and elements 359/629 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701692 | Smith et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | TASER International, Inc. (Scottsdale, Arizona) |
| INVENTOR(S) | Patrick W. Smith (Scottsdale, Arizona); Magne H. Nerheim (Paradise Valley, Arizona) |
| ABSTRACT | A projectile provides a stimulus signal through a human or animal target for immobilizing the target. The projectile includes a transceiver and a waveform generator. The transceiver receives a first signal and transmits a second signal. The waveform generator provides the stimulus signal through the target for immobilizing the target. The stimulus signal has a signal characteristic controlled by the waveform generator in accordance with the first signal. The second signal comprises a status of the stimulus signal. |
| FILED | Thursday, December 04, 2008 |
| APPL NO | 12/328655 |
| ART UNIT | 2836 — Electrical Circuits and Systems |
| CURRENT CPC | Electricity: Electrical systems and devices 361/232 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701987 | Savage-Leuchs et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Lockheed Martin Corporation (Bethesda, Maryland) |
| INVENTOR(S) | Matthias P. Savage-Leuchs (Woodinville, Washington); Eric C. Honea (Seattle, Washington) |
| ABSTRACT | Apparatus and method for generating controlled-linewidth laser-seed-signals for high-powered fiber-laser amplifier systems. In some embodiments, the natural chirp (frequency change of laser light over a short start-up time) of a DBR laser diode when driven by pulsed current is used to broaden the linewidth of the laser output, while adjusting the peak current and/or the pulse duration to obtain the desired linewidth. |
| FILED | Friday, January 12, 2007 |
| APPL NO | 11/623058 |
| ART UNIT | 2828 — Semiconductors/Memory |
| CURRENT CPC | Coherent light generators 372/25 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702178 | Bergen et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Sarnoff Corporation (Princeton, New Jersey) |
| INVENTOR(S) | James Bergen (Hopewell, New Jersey); Chao Zhang (Belle Mead, New Jersey); Gooitzen Van Der Wal (Hopewell, New Jersey) |
| ABSTRACT | A method and apparatus for reducing noise in at least one frame in an image sequence is disclosed. A minimum function is applied to the at least one frame to produce a plurality of minimum values. A mask is generated in accordance with the plurality of minimum values. The mask is applied to reduce the noise in the at least one frame. In one embodiment, impulse noise is reduced. In another embodiment wideband non-linear noise is reduced. |
| FILED | Tuesday, March 15, 2005 |
| APPL NO | 11/081255 |
| ART UNIT | 2624 — Selective Visual Display Systems |
| CURRENT CPC | Image analysis 382/275 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702381 | Gaeta et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Cornell Research Foundation, Inc. (Ithaca, New York) |
| INVENTOR(S) | Alexander L. Gaeta (Ithaca, New York); Dimitre G. Ouzounov (Ithaca, New York); Watt W. Webb (Ithaca, New York); Rebecca M. Williams (Ithaca, New York); Warren R. Zipfel (Ithaca, New York) |
| ABSTRACT | The present invention is directed to a method of applying radiation through an optical fiber for detecting disease within a plant or animal or other penetrable tissue, or imaging a particular tissue of a plant or animal. In addition, fluorescence and nonlinear scattering signals can be detected and localized within a subject by such application of radiation through an optical fiber. The radiation is effective to promote simultaneous multiphoton excitation. The optical fibers are used alone to examine internal regions of tissue, in conjunction with an optical biopsy needle to evaluate sub-surface tissue, or with an endoscope to evaluate tissue within body cavities. The present invention also relates to a device for coupling in radiation from an ultrashort mode-locked laser into the beam path of a microscope. |
| FILED | Monday, August 16, 2004 |
| APPL NO | 10/918950 |
| ART UNIT | 3737 — Selective Visual Display Systems |
| CURRENT CPC | Surgery 6/478 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702473 | Widder et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Army (Washington, District of Columbia) |
| INVENTOR(S) | Mark W. Widder (Waynesboro, Pennsylvania); Tommy R. Shedd (Middletown, Maryland); Mark W. Brown (Myersville, Maryland); Murray S. Swanson (Rockyridge, Maryland) |
| ABSTRACT | A submersible biomonitoring system for monitoring water quality in situ includes a submersible chamber constructed of a di-electric material and sized to allow suitable signals from one or more aquatic organisms to be received by eliminating cross-talk between cells while allowing ambient conditions to be maintained inside the chamber. The aquatic organism exhibits ventilatory behavior and body movement sensitive to water quality which manifest as electrical signals picked up by electrodes and communicated to a pre-amplifier that conditions the signals for communication to a land-based amplifier and/or controller that is used to interpret the signals to determine when the water to which the organism is exposed has caused physiological stress to the organism. |
| FILED | Tuesday, April 17, 2007 |
| APPL NO | 11/736437 |
| ART UNIT | 2863 — Printing/Measuring and Testing |
| CURRENT CPC | Data processing: Measuring, calibrating, or testing 72/50 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Department of Energy (DOE)
| US 07699033 | Bihari et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | UChicago Argonne, LLC (Chicago, Illinois) |
| INVENTOR(S) | Bipin Bihari (Woodridge, Illinois); Sreenath Borra Gupta (Naperville, Illinois); Ramanujam Raj Sekar (Naperville, Illinois) |
| ABSTRACT | A method and system to distribute high-power laser pulses to create sparks in individual cylinders of a multi-cylinder engine are provided. A laser provides laser output pulses. A distributor includes a linear array of mirrors with a respective mirror associated with one of the laser plugs. Each mirror is operatively controlled to move into a laser beam path to direct individual laser output pulses the associated laser plug for providing spark generation. The system enables correct cylinder firing order for predefined multi-cylinder firing sequences and allows for individual cylinder timing variation. |
| FILED | Tuesday, November 27, 2007 |
| APPL NO | 11/945714 |
| ART UNIT | 3747 — Thermal & Combustion Technology, Motive & Fluid Power Systems |
| CURRENT CPC | Internal-combustion engines 123/143.B00 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07699905 | Anderson et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Iowa State University Research Foundation, Inc. (Ames, Iowa) |
| INVENTOR(S) | Iver E. Anderson (Ames, Iowa); Robert L. Terpstra (Ames, Iowa) |
| ABSTRACT | A method of making dispersion-strengthened alloy particles involves melting an alloy having a corrosion and/or oxidation resistance-imparting alloying element, a dispersoid-forming element, and a matrix metal wherein the dispersoid-forming element exhibits a greater tendency to react with a reactive species acquired from an atomizing gas than does the alloying element. The melted alloy is atomized with the atomizing gas including the reactive species to form atomized particles so that the reactive species is (a) dissolved in solid solution to a depth below the surface of atomized particles and/or (b) reacted with the dispersoid-forming element to form dispersoids in the atomized particles to a depth below the surface of said atomized particles. The atomized alloy particles are solidified as solidified alloy particles or as a solidified deposit of alloy particles. Bodies made from the dispersion strengthened alloy particles, deposit thereof, exhibit enhanced fatigue and creep resistance and reduced wear as well as enhanced corrosion and/or oxidation resistance at high temperatures by virtue of the presence of the corrosion and/or oxidation resistance imparting alloying element in solid solution in the particle alloy matrix. |
| FILED | Monday, May 08, 2006 |
| APPL NO | 11/429918 |
| ART UNIT | 1793 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Specialized metallurgical processes, compositions for use therein, consolidated metal powder compositions, and loose metal particulate mixtures 075/332 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07699916 | Carter et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the United States Department of Energy (Washington, District of Columbia) |
| INVENTOR(S) | J. David Carter (Bolingbrook, Illinois); Jennifer R. Mawdsley (Woodridge, Illinois); Suhas Niyogi (Woodridge, Illinois); Xiaoping Wang (Naperville, Illinois); Terry Cruse (Lisle, Illinois); Lilia Santos (Lombard, Illinois) |
| ABSTRACT | A corrosion resistant, electrically-conductive, durable plate at least partially coated with an anchor coating and a corrosion resistant coating. The corrosion resistant coating made of at least a polymer and a plurality of corrosion resistant particles each having a surface area between about 1-20 m2/g and a diameter less than about 10 microns. Preferably, the plate is used as a bipolar plate in a proton exchange membrane (PEMFC) fuel cell stack. |
| FILED | Wednesday, May 28, 2008 |
| APPL NO | 12/128022 |
| ART UNIT | 1793 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Compositions: Coating or plastic 16/14.50 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07699946 | Zhao et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Los Alamos National Security, LLC (Los Alamos, New Mexico) |
| INVENTOR(S) | Yonghao Zhao (Los Alamos, New Mexico); Yuntian T. Zhu (Los Alamos, New Mexico) |
| ABSTRACT | A method for preparing a nanostructured aluminum alloy involves heating an aluminum alloy workpiece at temperature sufficient to produce a single phase coarse grained aluminum alloy, then refining the grain size of the workpiece at a temperature at or below room temperature, and then aging the workpiece to precipitate second phase particles in the nanosized grains of the workpiece that increase the ductility without decreasing the strength of the workpiece. |
| FILED | Monday, May 22, 2006 |
| APPL NO | 11/438929 |
| ART UNIT | 1793 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Metal treatment 148/577 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07699958 | Griffith et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | UT-Battelle, LLC (Oak Ridge, Tennessee) |
| INVENTOR(S) | William Louis Griffith (Oak Ridge, Tennessee); Alicia Lucille Compere (Knoxville, Tennessee); Carl Frederick Leitten, Jr. (Lenoir City, Tennessee) |
| ABSTRACT | A method for separating carbohydrates from pulping liquors includes the steps of providing a wood pulping or wood or biomass hydrolysis pulping liquor having lignin therein, and mixing the liquor with an acid or a gas which forms an acid upon contact with water to initiate precipitation of carbohydrate to begin formation of a precipitate. During precipitation, at least one long chain carboxylated carbohydrate and at least one cationic polymer, such as a polyamine or polyimine are added, wherein the precipitate aggregates into larger precipitate structures. Carbohydrate gel precipitates are then selectively removed from the larger precipitate structures. The method process yields both a carbohydrate precipitate and a high purity lignin. |
| FILED | Monday, November 27, 2006 |
| APPL NO | 11/563286 |
| ART UNIT | 1791 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Paper making and fiber liberation 162/16 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07699976 | Hansen et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Utah State University (North Logan, Utah) |
| INVENTOR(S) | Conly L. Hansen (North Logan, Utah); Carl S. Hansen (Garland, Utah); Kevin Pack (North Logan, Utah); John Milligan (North Logan, Utah); Bradley C. Benefiel (Idaho Falls, Idaho); C. Wayne Tolman (Rupert, Idaho); Kenneth W. Tolman (Rupert, Idaho) |
| ABSTRACT | An upflow bioreactor includes a vessel having an inlet and an outlet configured for upflow operation. A septum is positioned within the vessel and defines a lower chamber and an upper chamber. The septum includes an aperture that provides fluid communication between the upper chamber and lower chamber. The bioreactor also includes means for releasing pressure buildup in the lower chamber. In one configuration, the septum includes a releasable portion having an open position and a closed position. The releasable portion is configured to move to the open position in response to pressure buildup in the lower chamber. In the open position fluid communication between the lower chamber and the upper chamber is increased. Alternatively the lower chamber can include a pressure release line that is selectively actuated by pressure buildup. The pressure release mechanism can prevent the bioreactor from plugging and/or prevent catastrophic damage to the bioreactor caused by high pressures. |
| FILED | Thursday, October 12, 2006 |
| APPL NO | 11/548764 |
| ART UNIT | 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Liquid purification or separation 210/90 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700041 | Farmer et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Lawrence Livermore National Security, LLC (Livermore, California) |
| INVENTOR(S) | Joseph C. Farmer (Tracy, California); Larry E. Fischer (Los Gatos, California); Thomas E. Felter (Livermore, California) |
| ABSTRACT | A system for indirectly detecting a radiation source by directly detecting radiolytic products. The radiation source emits radiation and the radiation produces the radiolytic products. A fluid is positioned to receive the radiation from the radiation source. When the fluid is irradiated, radiolytic products are produced. By directly detecting the radiolytic products, the radiation source is detected. |
| FILED | Thursday, December 01, 2005 |
| APPL NO | 11/292827 |
| ART UNIT | 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Chemical apparatus and process disinfecting, deodorizing, preserving, or sterilizing 422/55 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700215 | Haltiner, Jr. et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Delphi Technologies, Inc. (Troy, Michigan) |
| INVENTOR(S) | Karl J. Haltiner, Jr. (Fairport, New York); James S. Vordonis (Penfield, New York) |
| ABSTRACT | A current carrier for a solid oxide fuel cell system comprising a current-carrying core formed of a high-conductivity metallic material such as copper, brass, bronze, silver, silver-copper alloys, molybdenum, tungsten, or the like, and a protective jacket surrounding the core material. Preferably, the jacket is metallurgically bonded to the core. The jacket is formed of a high temperature alloy such as stainless steel, nickel, or a nickel alloy. The jacket is structurally competent to maintain the form of the electrical carrier at elevated temperatures at which the core material may be structurally incompetent. The current carrier may be sized comparable to conventional copper cables. The carrier is attached to a fuel cell current collector by a clamp assembly having a large surface contact area. Preferably, a contact paste consisting of fine silver particles forms a diffusion bond between the clamp and the carrier jacket, resulting in a low-loss connection. |
| FILED | Wednesday, April 19, 2006 |
| APPL NO | 11/406873 |
| ART UNIT | 1795 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Chemistry: Electrical current producing apparatus, product, and process 429/37 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700334 | Camarero et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Lawrence Livermore National Security, LLC (Livermore, California) |
| INVENTOR(S) | Julio A. Camarero (Livermore, California); James J. De Yoreo (Clayton, California); Youngeun Kwon (Livermore, California) |
| ABSTRACT | Described herein is a method for the attachment of proteins to any solid support with control over the orientation of the attachment. The method is extremely efficient, not requiring the previous purification of the protein to be attached, and can be activated by UV-light. Spatially addressable arrays of multiple protein components can be generated by using standard photolithographic techniques. |
| FILED | Monday, March 19, 2007 |
| APPL NO | 11/688171 |
| ART UNIT | 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/177 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700517 | Li et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Battelle Memorial Institute (Richland, Washington) |
| INVENTOR(S) | Liyu Li (Richland, Washington); David L. King (Richland, Washington) |
| ABSTRACT | Octahedral molecular sieve sorbents and catalysts are disclosed, including silver hollandite and cryptomelane. These materials can be used, for example, to catalyze the oxidation of COx (e.g., CO), NOx (e.g., NO), hydrocarbons (e.g., C3H6) and/or sulfur-containing compounds. The disclosed materials also may be used to catalyze other reactions, such as the reduction of NO2. In some cases, the disclosed materials are capable of sorbing certain products from the reactions they catalyze. Silver hollandite, in particular, can be used to remove a substantial portion of certain sulfur-containing compounds from a gas or liquid by catalysis and/or sorption. The gas or liquid can be, for example, natural gas or a liquid hydrocarbon. |
| FILED | Friday, February 03, 2006 |
| APPL NO | 11/347459 |
| ART UNIT | 1793 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Catalyst, solid sorbent, or support therefor: Product or process of making 52/324 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700563 | Pena et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | BioSurface Engineering Technologies, Inc. (Rockville, Maryland); Brookhaven Science Associates (Upton, New York) |
| INVENTOR(S) | Louis A. Pena (Poquott, New York); Paul O. Zamora (Gaithersburg, Maryland); Xinhua Lin (Plainview, New York); John D. Glass (Shoreham, New York) |
| ABSTRACT | The invention provides synthetic heparin-binding growth factor analogs having at least one peptide chain, and preferably two peptide chains branched from a dipeptide branch moiety composed of two trifunctional amino acid residues, which peptide chain or chains bind a heparin-binding growth factor receptor and are covalently bound to a non-signaling peptide that includes a heparin-binding domain, preferably by a linker, which may be a hydrophobic linker. The synthetic heparin-binding growth factor analogs are useful as pharmaceutical agents, soluble biologics or as surface coatings for medical devices. |
| FILED | Tuesday, August 19, 2003 |
| APPL NO | 10/644703 |
| ART UNIT | 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/18 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700827 | Meagher et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The University of Georgia Research Foundation, Inc. (Athens, Georgia) |
| INVENTOR(S) | Richard B. Meagher (Athens, Georgia); Yujing Li (Athens, Georgia); Om P. Dhankher (Athens, Georgia) |
| ABSTRACT | The present disclosure provides a method of producing transgenic plants which are resistant to at least one metal ion by transforming the plant with a recombinant DNA comprising a nucleic acid encoding a bacterial arsenic reductase under the control of a plant expressible promoter, and a nucleic acid encoding a nucleotide sequence encoding a phytochelatin biosynthetic enzyme under the control of a plant expressible promoter. The invention also relates a method of phytoremediation of a contaminated site by growing in the site a transgenic plant expressing a nucleic acid encoding a bacterial arsenate reductase and a nucleic acid encoding a phytochelatin biosynthetic enzyme. |
| FILED | Thursday, December 13, 2001 |
| APPL NO | 10/450731 |
| ART UNIT | 1638 — Organic Chemistry |
| CURRENT CPC | Multicellular living organisms and unmodified parts thereof and related processes 8/278 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700832 | Altier et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Pioneer Hi-Bred International, Inc. (Johnston, Iowa); E.I. du Pont de Nemours and Company (Wilmington, Delaware); The Regents of the University of California (Oakland, California) |
| INVENTOR(S) | Daniel J. Altier (Granger, Iowa); Virginia C. Crane (Des Moines, Iowa); Irina Ellanskaya (Kyiv, Ukraine); Natalia Ellanskaya, legal representative (Kyiv, Ukraine); Jacob T. Gilliam (Norwalk, Iowa); Jennie Hunter-Cevera (Elliott City, Maryland); James K. Presnail (Avondale, Pennsylvania); Eric J. Schepers (Port Deposit, Maryland); Carl R. Simmons (Des Moines, Iowa); Tamas Torok (Richmond, California); Nasser Yalpani (Johnston, Iowa) |
| ABSTRACT | Compositions and methods for protecting a plant from a pathogen, particularly a fungal pathogen, are provided. Compositions include amino acid sequences, and variants and fragments thereof, for antipathogenic polypeptides that were isolated from fungal fermentation broths. Nucleic acids that encode the antipathogenic polypeptides are also provided. A method for inducing pathogen resistance in a plant using the nucleotide sequences disclosed herein is further provided. The method comprises introducing into a plant an expression cassette comprising a promoter operably linked to a nucleotide sequence that encodes an antipathogenic polypeptide of the invention. Compositions comprising an antipathogenic polypeptide or a transformed microorganism comprising a nucleic acid of the invention in combination with a carrier and methods of using these compositions to protect a plant from a pathogen are further provided. Transformed plants, plant cells, seeds, and microorganisms comprising a nucleotide sequence that encodes an antipathogenic polypeptide of the invention are also disclosed. |
| FILED | Wednesday, November 05, 2008 |
| APPL NO | 12/265461 |
| ART UNIT | 1638 — Organic Chemistry |
| CURRENT CPC | Multicellular living organisms and unmodified parts thereof and related processes 8/279 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701846 | Chen et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | International Business Machines Corporation (Armonk, New York) |
| INVENTOR(S) | Dong Chen (Croton On Hudson, New York); Alan Gara (Mount Kisco, New York); Philip Heidelberger (Cortlandt Manor, New York); Pavlos Vranas (Danville, California) |
| ABSTRACT | An apparatus and method for capturing data packets for analysis on a network computing system includes a sending node and a receiving node connected by a bi-directional communication link. The sending node sends a data transmission to the receiving node on the bi-directional communication link, and the receiving node receives the data transmission and verifies the data transmission to determine valid data and invalid data and verify retransmissions of invalid data as corresponding valid data. A memory device communicates with the receiving node for storing the invalid data and the corresponding valid data. A computing node communicates with the memory device and receives and performs an analysis of the invalid data and the corresponding valid data received from the memory device. |
| FILED | Tuesday, June 26, 2007 |
| APPL NO | 11/768572 |
| ART UNIT | 2471 — Multiplex and VoIP |
| CURRENT CPC | Multiplex communications 370/216 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702729 | Johanson et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | |
| INVENTOR(S) | Bradley E. Johanson (Palo Alto, California); Armando Fox (San Francisco, California); Terry A. Winograd (Stanford, California); Patrick M. Hanrahan (Portola Valley, California) |
| ABSTRACT | An efficient and adaptive middleware infrastructure called the Event Heap system dynamically coordinates application interactions and communications in a ubiquitous computing environment, e.g., an interactive workspace, having heterogeneous software applications running on various machines and devices across different platforms. Applications exchange events via the Event Heap. Each event is characterized by a set of unordered, named fields. Events are routed by matching certain attributes in the fields. The source and target versions of each field are automatically set when an event is posted or used as a template. The Event Heap system implements a unique combination of features, both intrinsic to tuplespaces and specific to the Event Heap, including content based addressing, support for routing patterns, standard routing fields, limited data persistence, query persistence/registration, transparent communication, self-description, flexible typing, logical/physical centralization, portable client API, at most once per source first-in-first-out ordering, and modular restartability. |
| FILED | Thursday, April 08, 2004 |
| APPL NO | 10/821756 |
| ART UNIT | 2451 — Computer Networks |
| CURRENT CPC | Electrical computers and digital processing systems: Multicomputer data transferring 79/205 |
| VIEW PATENT | @ USPTO: Full Text PDF |
National Science Foundation (NSF)
| US 07698930 | Gordaninejad et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Board of Regents of the Nevada System of Higher Education on behalf of the University of Nevada, Reno (Reno, Nevada) |
| INVENTOR(S) | Faramarz Gordaninejad (Reno, Nevada); Joseph L. Whiteley (Gardnerville, Nevada) |
| ABSTRACT | Methods and apparatus are disclosed for characterizing flow of magneto-rheological suspensions through microchannels. The apparatus includes a pump for pumping a the magneto-rheological suspension; a microchannel hydraulically coupled to the pump and configured to receive the magneto-rheological suspension from the pump; a manifold hydraulically coupled between an outlet of the microchannel and the pump; a static pressure tap configured to convey a static pressure of the manifold; a pressure sensor hydraulically coupled to the pressure tap and configured to receive the static pressure conveyed therefrom; and a magnet positioned to direct a magnetic field toward the microchannel and contents disposed therein. |
| FILED | Tuesday, April 03, 2007 |
| APPL NO | 11/732700 |
| ART UNIT | 2856 — Printing/Measuring and Testing |
| CURRENT CPC | Measuring and testing 073/54.90 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700200 | Bulović et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Massachusetts Institute of Technology (Cambridge, Massachusetts); Universal Display Corporation (Ewing, New Jersey) |
| INVENTOR(S) | Vladimir Bulović (Lexington, Massachusetts); Seth A. Coe (Watertown, Massachusetts); Wing-Keung Woo (Cambridge, Massachusetts); Moungi G. Bawendi (Boston, Massachusetts) |
| ABSTRACT | A light emitting device includes a semiconductor nanocrystal in a layer. The layer can be a non-polymeric layer. |
| FILED | Friday, March 28, 2003 |
| APPL NO | 10/400908 |
| ART UNIT | 1794 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Stock material or miscellaneous articles 428/690 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700347 | Levin |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Forsyth Institute (Boston, Massachusetts) |
| INVENTOR(S) | Michael Levin (Swampscott, Massachusetts) |
| ABSTRACT | The invention provides apparatuses, systems, and methods for conducting assays in aquatic animals. The apparatuses, systems, and methods of the invention can be used to identify and/or characterize compounds that modulate morphological, anatomical, or behavioral characteristics. The apparatuses, systems, and methods of the invention can be used to identify and/or characterize compounds that modulate learning or memory. |
| FILED | Thursday, June 29, 2006 |
| APPL NO | 11/477259 |
| ART UNIT | 1641 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/288.400 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700798 | Davies et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Research Foundation of State University of New York (Amherst, New York) |
| INVENTOR(S) | Huw M. L. Davies (East Amherst, New York); Abbas M. Walji (Pasadena, California) |
| ABSTRACT | Disclosed are compounds having the formula: wherein R21 is an alkyl, aryl, alkoxy, hydroxy, or amino group or a halogen atom; wherein R2 is hydrogen or an alkyl, aryl, alkoxy, or amino group; wherein R23 and R24 are independently selected from hydrogen, an alkyl, aryl, alkoxy, hydroxy, or amino group, and a halogen atom or wherein R23 and R24, taken together with the carbon atom to which they are bound, form a ring; wherein R25 is hydrogen, an alkyl, aryl, alkoxy, hydroxy, or O-silyl group or a halogen atom; wherein Z, taken together with the carbons to which it is bonded, forms a 5-12 membered ring; and wherein Y is an electron withdrawing group. These compounds can be used to prepare erogorgiaene congeners, such as erogorgiaene, pseudopterosin A, helioporin E, pseudopteroxazole, colombiasin A, elisapoterosin B, elisabethadione, p-benzoquinone natural products, ileabethin, sinulobtain B, sinulobtain C, and sinulobtain D. |
| FILED | Thursday, June 08, 2006 |
| APPL NO | 11/449143 |
| ART UNIT | 1621 — Organic Chemistry |
| CURRENT CPC | Organic compounds 560/56 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701227 | Saulnier et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Rensselaer Polytechnic Institute (Troy, New York) |
| INVENTOR(S) | Gary J. Saulnier (East Greenbush, New York); Ning Liu (Troy, New York); Alexander S. Ross (Albany, New York) |
| ABSTRACT | An EIT system includes a plurality of voltage sources for supplying a corresponding plurality of voltages to a corresponding number of other structures, voltage source calibration means for calibrating each voltage source, and switching means for individually connecting the calibration means to each voltage source in succession during a period when each other structure is in an inactive condition. Calibrating respective voltages and currents for each voltage source compensates for shunt impedance of each voltage source. A method for calibrating the system includes individually connecting the calibration means to each voltage source in succession during a period when each other structure is in an inactive condition for calibrating all of said voltage sources in the same way. |
| FILED | Friday, December 30, 2005 |
| APPL NO | 11/722159 |
| ART UNIT | 2831 — Electrical Circuits and Systems |
| CURRENT CPC | Electricity: Measuring and testing 324/601 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702106 | Mimih et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | MagiQ Technologies, Inc. (New York, New York) |
| INVENTOR(S) | Jihane Mimih (San Francisco, California); Mark Hillery (Metuchen, New Jersey); Ekaterina Rogacheva (Boston, Massachusetts) |
| ABSTRACT | Systems and methods for quantum secret splitting based on non-orthogonal multi-particle states are disclosed. The method includes preparing at a sender (“Charlie”) two qubits each of which can be in one of two non-orthogonal states and distributing the qubits to respective parties Alice and Bob. The method also includes measuring at Alice the state of the qubit she receives by a projective measurement so that the measurement result is either 0 or 1, and at Bob measuring the state of the qubit he receives such that the measurement result is either 0, 1 or f, wherein f represents a failure by Bob to properly measure the qubit state. The method also includes communicating between Alice, Bob and Charlie the outcome of their respective measurements so as to deduce the state of the qubits sent to Alice and Bob. |
| FILED | Friday, January 12, 2007 |
| APPL NO | 11/653056 |
| ART UNIT | 2435 — Cryptography and Security |
| CURRENT CPC | Cryptography 380/256 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702381 | Gaeta et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Cornell Research Foundation, Inc. (Ithaca, New York) |
| INVENTOR(S) | Alexander L. Gaeta (Ithaca, New York); Dimitre G. Ouzounov (Ithaca, New York); Watt W. Webb (Ithaca, New York); Rebecca M. Williams (Ithaca, New York); Warren R. Zipfel (Ithaca, New York) |
| ABSTRACT | The present invention is directed to a method of applying radiation through an optical fiber for detecting disease within a plant or animal or other penetrable tissue, or imaging a particular tissue of a plant or animal. In addition, fluorescence and nonlinear scattering signals can be detected and localized within a subject by such application of radiation through an optical fiber. The radiation is effective to promote simultaneous multiphoton excitation. The optical fibers are used alone to examine internal regions of tissue, in conjunction with an optical biopsy needle to evaluate sub-surface tissue, or with an endoscope to evaluate tissue within body cavities. The present invention also relates to a device for coupling in radiation from an ultrashort mode-locked laser into the beam path of a microscope. |
| FILED | Monday, August 16, 2004 |
| APPL NO | 10/918950 |
| ART UNIT | 3737 — Selective Visual Display Systems |
| CURRENT CPC | Surgery 6/478 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Department of Agriculture (USDA)
| US 07698853 | Ragon et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Mississippi State University Research and Technology Corporation (Mississippi State, Mississippi) |
| INVENTOR(S) | Kevin W. Ragon (Sturgis, Mississippi); J. Patrick Donohoe (Starkville, Mississippi); Terry Amburgey (Sturgis, Mississippi); Michael Sanders (Sturgis, Mississippi) |
| ABSTRACT | The present invention provides methods and apparatus for controlling insect population or activity by using electromagnetic field source of certain frequency and intensity coupled with insect food sources/attractants. The present invention can be used to protect a natural or man-made structure from termite infestation. The present invention can also be used for controlling activity of other social insects such as ants, bees and wasps. |
| FILED | Tuesday, September 27, 2005 |
| APPL NO | 11/235109 |
| ART UNIT | 3643 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review |
| CURRENT CPC | Fishing, trapping, and vermin destroying 043/132.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07699976 | Hansen et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Utah State University (North Logan, Utah) |
| INVENTOR(S) | Conly L. Hansen (North Logan, Utah); Carl S. Hansen (Garland, Utah); Kevin Pack (North Logan, Utah); John Milligan (North Logan, Utah); Bradley C. Benefiel (Idaho Falls, Idaho); C. Wayne Tolman (Rupert, Idaho); Kenneth W. Tolman (Rupert, Idaho) |
| ABSTRACT | An upflow bioreactor includes a vessel having an inlet and an outlet configured for upflow operation. A septum is positioned within the vessel and defines a lower chamber and an upper chamber. The septum includes an aperture that provides fluid communication between the upper chamber and lower chamber. The bioreactor also includes means for releasing pressure buildup in the lower chamber. In one configuration, the septum includes a releasable portion having an open position and a closed position. The releasable portion is configured to move to the open position in response to pressure buildup in the lower chamber. In the open position fluid communication between the lower chamber and the upper chamber is increased. Alternatively the lower chamber can include a pressure release line that is selectively actuated by pressure buildup. The pressure release mechanism can prevent the bioreactor from plugging and/or prevent catastrophic damage to the bioreactor caused by high pressures. |
| FILED | Thursday, October 12, 2006 |
| APPL NO | 11/548764 |
| ART UNIT | 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Liquid purification or separation 210/90 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07699979 | Li et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Board of Trustees of the University of Arkansas (Little Rock, Arkansas) |
| INVENTOR(S) | Yanbin Li (Fayetteville, Arkansas); Madhukar Varshney (Fayetteville, Arkansas); Zunzhang Ye (Fayetteville, Arkansas) |
| ABSTRACT | Methods are disclosed for the capture, detection, separation, isolation and quantification of contaminants in a starting material. Also disclosed are competitive assay methods for the detection and quantification of contaminants in a starting material. Kits for use with the method are disclosed as well. A system for capturing, separating and/or concentrating contaminants from a material is also presented. The system captures, separates and/or concentrates contaminants such as bacteria, viruses, other microorganisms, and/or larger items, such as insects, from a variety of materials, such as food, and environmental and clinical materials. In general, the system uses a rotating magnetic field to mix the material with magnetic particles to capture the target contaminants, and a fixed magnetic field to separate and concentrate the captured target contaminants. |
| FILED | Monday, January 09, 2006 |
| APPL NO | 11/328808 |
| ART UNIT | 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Liquid purification or separation 210/138 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700349 | Romaine et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Penn State Research Foundation (University Park, Pennsylvania) |
| INVENTOR(S) | C. Peter Romaine (State College, Pennsylvania); Xi Chen (Durham, North Carolina) |
| ABSTRACT | Applicants have devised a highly effective, convenient, and expeditious genetic transformation system for filamentous fungi, such as Agaricus bisporus. The preferred method uses an Agrobacterium-mediated transformation protocol. The critical features of this protocol include co-cultivation of the bacterium with fruit body tissue instead of spores. In a preferred embodiment, even higher transformation efficiencies were observed with the use of a homologous promoter in the polynucleotide expression construct in order to drive gene expression. |
| FILED | Thursday, September 30, 2004 |
| APPL NO | 10/955146 |
| ART UNIT | 1638 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/320.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700356 | Horn et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of Agriculture (Washington, District of Columbia) |
| INVENTOR(S) | Carsten Horn (Berlin, Germany); Alfred M. Handler (Gainesville, Florida) |
| ABSTRACT | The novel germ-line transformation systems disclosed in this patent application allow the physical deletion of transposon DNA following the transformation process, and the targeting of transgene integrations into predefined target sites. In this way, transposase-mediated mobilization of genes-of-interest is excluded mechanistically and random genomic integrations eliminated. In contrast to conventional germ-line transformation technology, our systems provide enhanced stability to the transgene insertion. Furthermore, DNA sequences required for the transgene modification (e.g. transformation marker genes, transposase or recombinase target sites), are largely removed from the genome after the final transgene insertion, thereby eliminating the possibility for instability generated by these processes. The RMCE technology, which is disclosed in this patent application for invertebrate organisms (exemplified in Drosophila melanogaster) represents an extremely versatile tool with application potential far beyond the goal of transgene immobilization. RMCE makes possible the targeted integration of DNA cassettes into a specific genomic loci that are pre-defined by the integration of the RMCE acceptor plasmid. The loci can be characterized prior to a targeting experiment allowing optimal integration sites to be pre-selected for specific applications, and allowing selection of host strains with optimal fitness. In addition, multiple cassette exchange reactions can be performed in a repetitive way where an acceptor cassette can be repetitively exchanged by multiple donor cassettes. In this way several different transgenes can be placed precisely at the same genomic locus, allowing, for the first time, the ability to eliminate genomic positional effects and to comparatively study the biological effects of different transgenes. |
| FILED | Friday, November 07, 2003 |
| APPL NO | 10/534226 |
| ART UNIT | 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/455 |
| VIEW PATENT | @ USPTO: Full Text PDF |
National Aeronautics and Space Administration (NASA)
| US 07700157 | Bronikowski et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | California Institute of Technology (Pasadena, California) |
| INVENTOR(S) | Michael J. Bronikowski (Altadena, California); Brian D. Hunt (La Crescenta, California) |
| ABSTRACT | A method of forming a periodic array of nano-scale objects using a block copolymer, and nano-scale object arrays formed from the method are provided. The method for forming the arrays generally includes the steps of depositing a block copolymer of at least two blocks on a substrate to form an ordered meso-scale structured array of the polymer materials, forming catalytic metal dots based on the meso-scale structure, and growing nano-scale objects on the catalytic dots to form an ordered array of nano-scale objects. |
| FILED | Tuesday, August 22, 2006 |
| APPL NO | 11/508514 |
| ART UNIT | 1792 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Coating processes 427/249.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701145 | Stone et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | NeXolve Corporation (Huntsville, Alabama) |
| INVENTOR(S) | Nobie H. Stone (Huntsville, Alabama); Garrett D. Poe (Madison, Alabama); Robert Rood (Union Grove, Alabama) |
| ABSTRACT | An improved solid expellant plasma generator has been developed. The plasma generator includes a support housing, an electrode rod located in the central portion of the housing, and a mass of solid expellant material that surrounds the electrode rod within the support housing. The electrode rod and the solid expellant material are made of separate materials that are selected so that the electrode and the solid expellant material decompose at the same rate when the plasma generator is ignited. This maintains a point of discharge of the plasma at the interface between the electrode and the solid expellant material. |
| FILED | Friday, September 07, 2007 |
| APPL NO | 11/852007 |
| ART UNIT | 2821 — Electrical Circuits and Systems |
| CURRENT CPC | Electric lamp and discharge devices: Systems 315/111.110 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701202 | Torres-Jara |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Massachusetts Institute of Technology (Cambridge, Massachusetts) |
| INVENTOR(S) | Eduardo Torres-Jara (Cambridge, Massachusetts) |
| ABSTRACT | Tactile Sensor. The sensor includes a compliant convex surface disposed above a sensor array, the sensor array adapted to respond to deformation of the convex surface to generate a signal related to an applied force vector. The applied force vector has three components to establish the direction and magnitude of an applied force. The compliant convex surface defines a dome with a hollow interior and has a linear relation between displacement and load including a magnet disposed substantially at the center of the dome above a sensor array that responds to magnetic field intensity. |
| FILED | Thursday, November 02, 2006 |
| APPL NO | 11/591709 |
| ART UNIT | 2858 — Printing/Measuring and Testing |
| CURRENT CPC | Electricity: Measuring and testing 324/207.200 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701561 | Zou et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Boston Applied Technologies Incorporated (Woburn, Massachusetts) |
| INVENTOR(S) | Yingyin Kevin Zou (Lexington, Massachusetts); Qiushui Chen (Andover, Massachusetts); Hongzhi Zhao (Malden, Massachusetts) |
| ABSTRACT | A polarization imaging apparatus measures the Stokes image of a sample. The apparatus consists of an optical lens set 11, a linear polarizer 14 with its optical axis 18, a first variable phase retarder 12 with its optical axis 16 aligned 22.5° to axis 18, a second variable phase retarder 13 with its optical axis 17 aligned 45° to axis 18, a imaging sensor 15 for sensing the intensity images of the sample, a controller 101 and a computer 102. Two variable phase retarders 12 and 13 were controlled independently by a computer 102 through a controller unit 101 which generates a sequential of voltages to control the phase retardations of VPRs 12 and 13. A set of four intensity images, I0, I1, I2 and I3 of the sample were captured by imaging sensor 15 when the phase retardations of VPRs 12 and 13 were set at (0,0), (π,0), (π,π) and (π/2,π), respectively Then four Stokes components of a Stokes image, S0, S1, S2 and S3 were calculated using the four intensity images. |
| FILED | Friday, February 02, 2007 |
| APPL NO | 11/701738 |
| ART UNIT | 2886 — Optics |
| CURRENT CPC | Optics: Measuring and testing 356/73 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702427 | Sridhar et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the National Aeronautics and Space Administration (NASA) (Washington, District of Columbia) |
| INVENTOR(S) | Banavar Sridhar (Los Altos, California); Kapil S. Sheth (Campbell, California); Gano Broto Chatterji (Sunnyvale, California); Karl D. Bilimoria (San Jose, California); Shon Grabbe (San Jose, California); John F. Schipper (Palo Alto, California) |
| ABSTRACT | Method and system for evaluating and implementing air traffic management tools and approaches for managing and avoiding an air traffic incident before the incident occurs. The invention provides flight plan routing and direct routing or wind optimal routing, using great circle navigation and spherical Earth geometry. The invention provides for aircraft dynamics effects, such as wind effects at each altitude, altitude changes, airspeed changes and aircraft turns to provide predictions of aircraft trajectory (and, optionally, aircraft fuel use). A second system provides several aviation applications using the first system. These applications include conflict detection and resolution, miles-in trail or minutes-in-trail aircraft separation, flight arrival management, flight re-routing, weather prediction and analysis and interpolation of weather variables based upon sparse measurements. |
| FILED | Friday, July 30, 2004 |
| APPL NO | 10/914783 |
| ART UNIT | 3664 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems |
| CURRENT CPC | Data processing: Vehicles, navigation, and relative location 71/4 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Department of Commerce (DOC)
| US 07700278 | Paul et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of South Florida (Tampa, Florida) |
| INVENTOR(S) | John H Paul (St. Petersburg, Florida); Mike Gray (St. Petersburg, Florida); Erica Casper (St. Petersburg, Florida) |
| ABSTRACT | A real-time reverse transcription-PCR, or NABSA, method targeting the rbcL gene developed for the detection and quantitation of the Florida red tide organism, Karenia brevis. |
| FILED | Thursday, January 08, 2004 |
| APPL NO | 10/707747 |
| ART UNIT | 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/6 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700787 | Ong et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Xerox Corporation (Norwalk, Connecticut) |
| INVENTOR(S) | Beng S Ong (Singapore, Singapore); Ping Liu (Mississauga, Canada); Maria Birau (Mississauga, Canada); Yiliang Wu (Mississauga, Canada) |
| ABSTRACT | A small molecular thiophene compound consisting of a plurality of thiophene units, each thiophene unit being represented by structure (A) wherein each thiophene unit is bonded at either or both of the second ring position and the fifth ring position, wherein m is 0, 1, or 2, wherein each thiophene unit is the same or different from each other in terms of substituent number, substituent identity, and substituent position, wherein each R1 is independently selected from the group consisting of: (a) a hydrocarbon group, (b) a heteroatom containing group, and (c) a halogen, wherein there is at least one thiophene unit where R1 is present at the third ring position or the fourth ring position, or at both the third ring position and the fourth ring position, wherein for any two adjacent thiophene units as represented by structure (A1): there is excluded the simultaneous presence of the same or different R1 at the 3-position of one thiophene unit and at the 3′-position of the other thiophene unit wherein R1 is not part of a cyclic ring structure fused to the thiophene unit. |
| FILED | Tuesday, October 30, 2007 |
| APPL NO | 11/927871 |
| ART UNIT | 1625 — Organic Chemistry |
| CURRENT CPC | Organic compounds 549/59 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07702611 | Chi et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Xerox Corporation (Norwalk, Connecticut) |
| INVENTOR(S) | Ed H. Chi (Palo Alto, California); Lichan Hong (Mountain View, California); Stuart K. Card (Los Altos Hills, California) |
| ABSTRACT | User's interests can be explicitly determined via keywords that the user specifies, and/or are implicitly constructed from user browsing and reading activity. User interests may be expressed as an interest profile. Conceptual keywords related to user interests are selected by combining spreading activation and word co-occurrence, by latent semantic analysis, or other methods. One embodiment automatically highlights sentences and other information that contain conceptual keywords related to user interests. Highlights can be activated when the user directly performs a keyword search or index search, or the invention can generate information reflecting user interests, apply it to the text, and generate and display highlights. One embodiment includes an algorithm for computing a conceptual keyword vector through an iterative spreading activation process also employing word co-occurrence. A conceptual index of the text may be created and then combined with conceptual highlighting. |
| FILED | Friday, January 07, 2005 |
| APPL NO | 11/031641 |
| ART UNIT | 2164 — Data Bases & File Management |
| CURRENT CPC | Data processing: Database and file management or data structures 77/1 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Small Business Administration (SBA)
| US 07700284 | Romanov et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Attagene, Inc. (Morrisville, North Carolina) |
| INVENTOR(S) | Sergei R. Romanov (Chapel Hill, North Carolina); Alex Medvedev (Durham, North Carolina); Sergei S. Makarov (Chapel Hill, North Carolina) |
| ABSTRACT | Compositions, methods and kits are provided that are useful, for example, for determining activities of multiple cis-regulatory sequences, such as promoters and enhancers, and/or multiple trans-acting factors, such as transcription factors, in a cell. In particular, in certain embodiments, compositions are provided comprising a population of polynucleotide reporter transcription units (RTUs) in which each RTU comprises a reporter sequence, a processing tag located in the reporter sequence; and a cis-regulatory element operably linked to the reporter sequence, wherein the reporter sequences between any two RTUs in the population, outside of the processing tags, are substantially identical and wherein the positions of the processing tags within the reporter sequences distinguish between any two RTUs differing, for example, in their cis-regulatory elements. The compositions, methods and kits can further be used, for example, to identify a cell type or disease state, for example, in a biological organism. |
| FILED | Thursday, November 10, 2005 |
| APPL NO | 11/271190 |
| ART UNIT | 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/6 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700354 | Rich |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | HemoGenix, Inc. (Colorado Springs, Colorado) |
| INVENTOR(S) | Ivan N. Rich (Colorado Springs, Colorado) |
| ABSTRACT | The present invention relates generally to high-throughput assay methods that determine the proliferative status of hematopoietic stem and progenitor cells. The present invention further relates to high-throughput assays for screening compounds that modulate the growth of hematopoietic stem and progenitor cells and for identifying subpopulations thereof that are suitable for transplantation. The assay of the present invention is particularly useful for quality control and monitoring of the growth potential in the stem cell transplant setting and would provide improved control over the reconstitution phase of transplanted cells. |
| FILED | Monday, March 17, 2008 |
| APPL NO | 12/049815 |
| ART UNIT | 1641 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/375 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07701380 | Altes |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Chirp Corporation (La Jolla, California) |
| INVENTOR(S) | Richard Alan Altes (La Jolla, California) |
| ABSTRACT | Phase modulated beam patterns are substituted for the constant-phase versions that have been used in prior synthetic aperture systems. Relative movement between a radar/sonar/ultrasound platform and a point target causes a sequence of echoes from the point target to be phase and amplitude modulated by the beam pattern, as well as by the usual quadratic phase variation caused by range changes. Azimuth, range rate, and azimuth rate estimation, as well as detection in clutter, are substantially improved by appropriate beam pattern phase modulation, which is applied to the transmitter and/or receiver beam patterns. Phase modulated beam patterns are synthesized with array element weighting functions that are designed for high ambiguity function peak-to-sidelobe level, reduction of unwanted ambiguity ridge lines, and adequate spatial sampling. Two dimensional beam pattern phase modulation is useful when the relative motion between a transmit-receive array and multiple targets has both azimuth and elevation components. |
| FILED | Wednesday, March 07, 2007 |
| APPL NO | 11/714797 |
| ART UNIT | 3662 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems |
| CURRENT CPC | Communications: Directive radio wave systems and devices 342/25.F00 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Department of Transportation (USDOT)
| US 07699288 | Kimbrew |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Texas Department of Transportation (Austin, Texas) |
| INVENTOR(S) | Kade Allen Kimbrew (Electra, Texas) |
| ABSTRACT | A system and method for extracting broken delineators severed adjacent to a ground surface where the delineator was installed. A distal end of a delineator extractor may be positionable in a delineator conduit. At least a portion of the distal end of the delineator extractor may be configured to engage an interior surface of the delineator conduit when the delineator extractor is activated. Upon the delineator extractor engaging the delineator conduit, a user may activate a slide hammer of the delineator extractor to amplify a force applied by the user to assist in extracting the delineator conduit. A delineator extraction system may include an installer couplable to a distal end of an outer conduit of a delineator extractor. The installer may function to install or extract a delineator system. |
| FILED | Tuesday, March 25, 2008 |
| APPL NO | 12/055122 |
| ART UNIT | 3632 — Static Structures, Supports and Furniture |
| CURRENT CPC | Supports 248/544 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700157 | Bronikowski et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | California Institute of Technology (Pasadena, California) |
| INVENTOR(S) | Michael J. Bronikowski (Altadena, California); Brian D. Hunt (La Crescenta, California) |
| ABSTRACT | A method of forming a periodic array of nano-scale objects using a block copolymer, and nano-scale object arrays formed from the method are provided. The method for forming the arrays generally includes the steps of depositing a block copolymer of at least two blocks on a substrate to form an ordered meso-scale structured array of the polymer materials, forming catalytic metal dots based on the meso-scale structure, and growing nano-scale objects on the catalytic dots to form an ordered array of nano-scale objects. |
| FILED | Tuesday, August 22, 2006 |
| APPL NO | 11/508514 |
| ART UNIT | 1792 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Coating processes 427/249.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
National Security Agency (NSA)
| US 07700387 | Fitz et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as Represented by the Director, National Security Agency (Washington, District of Columbia) |
| INVENTOR(S) | John L. Fitz (Windsor Mill, Maryland); Daniel S. Hinkel (Sykesville, Maryland); Scott C. Horst (Sykesville, Maryland) |
| ABSTRACT | The present invention is a method of fabricating an optical device using multiple sacrificial spacer layers. The first step in this process is to fabricate the underlying base structure and deposit an optical structure thereon. A facet is then created at the ends of the optical structure and alternating sacrificial and intermediate layers are fabricated on the device. A mask layer is deposited on the structure, with openings created in the layers to allow use of an etchant. User-defined portions of the spacer layers are subsequently removed with the etchant to create air gaps between the intermediate layers. |
| FILED | Tuesday, May 05, 2009 |
| APPL NO | 12/454023 |
| ART UNIT | 2822 — Semiconductors/Memory |
| CURRENT CPC | Semiconductor device manufacturing: Process 438/29 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07700391 | Fitz et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | U.S. Government as Represented by the Director, National Security Agency, The (Washington, District of Columbia) |
| INVENTOR(S) | John L. Fitz (Windsor Mill, Maryland); Daniel S. Hinkel (Sykesville, Maryland); Scott C. Horst (Sykesville, Maryland) |
| ABSTRACT | The present invention is a method of fabricating an optical device using multiple sacrificial spacer layers. The first step in this process is to fabricate the underlying base structure and deposit an optical structure thereon. A facet is then created at the ends of the optical structure and alternating sacrificial and intermediate layers are fabricated on the device. A mask layer is deposited on the structure, with openings created in the layers to allow use of an etchant. User-defined portions of the spacer layers are subsequently removed with the etchant to create air gaps between the intermediate layers. |
| FILED | Tuesday, May 05, 2009 |
| APPL NO | 12/454040 |
| ART UNIT | 2822 — Semiconductors/Memory |
| CURRENT CPC | Semiconductor device manufacturing: Process 438/31 |
| VIEW PATENT | @ USPTO: Full Text PDF |
U.S. State Government
| US 07699288 | Kimbrew |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Texas Department of Transportation (Austin, Texas) |
| INVENTOR(S) | Kade Allen Kimbrew (Electra, Texas) |
| ABSTRACT | A system and method for extracting broken delineators severed adjacent to a ground surface where the delineator was installed. A distal end of a delineator extractor may be positionable in a delineator conduit. At least a portion of the distal end of the delineator extractor may be configured to engage an interior surface of the delineator conduit when the delineator extractor is activated. Upon the delineator extractor engaging the delineator conduit, a user may activate a slide hammer of the delineator extractor to amplify a force applied by the user to assist in extracting the delineator conduit. A delineator extraction system may include an installer couplable to a distal end of an outer conduit of a delineator extractor. The installer may function to install or extract a delineator system. |
| FILED | Tuesday, March 25, 2008 |
| APPL NO | 12/055122 |
| ART UNIT | 3632 — Static Structures, Supports and Furniture |
| CURRENT CPC | Supports 248/544 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Government Rights Acknowledged
| US 07701891 | Barnhart et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Raytheon Company (Waltham, Massachusetts) |
| INVENTOR(S) | Randy C. Barnhart (Parker, Colorado); Donald V. Schnaidt (Centennial, Colorado); Steven W. Talcott (Larkspur, Colorado); Craig S. Kloosterman (Denver, Colorado); Melinda C. Milani (Parker, Colorado) |
| ABSTRACT | In one embodiment, a system for data handling in a distributed communication network includes one or more data-handling nodes (DHNs) each residing at one of one or more centrals that are each operable to receive a stream of first data units from a routing system. The stream of first data units includes both stored mission data (SMD) and telemetry data having originated at one or more remote units. Each DHN is operable, in near real time, to remove redundant instances of first data units from the stream of first data units, properly order first data units in the stream of first data units received at the central out of order, remove misconfigured first data units from the stream of first data units, extract the SMD from the stream of first data units, generate second data units from the extracted SMD, and communicate a stream of the second data units to one or more interface data processors (IDPs). |
| FILED | Friday, March 18, 2005 |
| APPL NO | 11/083379 |
| ART UNIT | 2473 — Multiplex and VoIP |
| CURRENT CPC | Multiplex communications 370/316 |
| VIEW PATENT | @ USPTO: Full Text PDF |
How To Use This Page
THE FEDINVENT PATENT DETAILS PAGE
Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.
This week's information is published in the FedInvent Patents report for Tuesday, April 20, 2010.
The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.
HOW IS THE INFORMATION ORGANIZED?
Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.
WHAT INFORMATION WILL I FIND?
THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:
FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Army Research Office (ARO)
We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.
APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.
Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:
APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC
APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)
INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.
ABSTRACT
The abstract as it appears on the patent.
FILED
The date of the patent application including the day of the week.
APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.
ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:
3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.
CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.
The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.
The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.
- A61B 1/149 (20130101)
- A61B 1/71 (20130101)
- A61B 1/105 (20130101)
The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.
VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.
HOW DO I FIND A SPECIFIC PATENT ON A PAGE?
You can use the Command F or Control F to find a specific patent you are interested in.
HOW DO I GET HERE?
You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.
You can also reach this page using the weekly page link that looks like this:
https://wayfinder.digital/fedinvent/patents-2010/fedinvent-patents-20100420.html
Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.
Download a copy of the How To Use This Page